THIP KPI 2024

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 92 ĀöüéêĆüßĊĚüĆé Chronic disease ðøąđõìêĆüßĊĚüĆé DM øĀĆÿêĆüßĊĚüĆé DC0103 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úą×ĂÜñĎšðśü÷đïćĀüćîĕéšøĆïÖćøÙĆéÖøĂÜđïćĀüćîđךćÝĂðøąÿćìêć ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) DM: Percent of diabetic retinopathy screening îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷đïćĀüćî Āöć÷ëċÜ ñĎšðśü÷ìĆĚÜĔîÿëćîąñĎšðśü÷ĔîĒúąñĎšðśü÷îĂÖ ìĊęĕéšøĆïÖćø üĉîĉÝÞĆ÷ēøÙđïćĀüćî ĒúąđðŨîñĎšðśü÷ìĊę×ċĚîìąđïĊ÷îøĆïÖćøøĆÖþćÖĆïēøÜó÷ćïćúàċęÜöćøĆïÖćø êøüÝêĉéêćöĔîÙúĉîĉÖ œ 2 ÙøĆĚÜĔî 6 đéČĂî ĀøČĂ œ 3 ÙøĆĚÜĔî 1 ðŘēé÷đðŨîēøÙìĊęöĊøĀĆÿēøÙ êćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ÖćøÙĆéÖøĂÜđïćĀüćîđךćÝĂðøąÿćìêć Āöć÷ëċÜ ñĎšðśü÷đïćĀüćîìĊęöćøĆïïøĉÖćøìĊę ēøÜó÷ćïćúĕéšøĆïÖćøêøüÝÝĂðøąÿćìêćĂ÷ŠćÜúąđĂĊ÷é ēé÷ÝĆÖþčĒóì÷ŤĀøČĂÙĆéÖøĂÜéšü÷ Fundus Camera Ă÷ŠćÜîšĂ÷ ðŘúą 1ÙøĆĚÜ üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé úéÙüćöđÿĊę÷ÜÝćÖõćüąĒìøÖàšĂîÝćÖđïćĀüćî ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷đïćĀüćîìĊęĕéšøĆïÖćøêøüÝÝĂðøąÿćìêć Ă÷ŠćÜîšĂ÷ðŘúą 1 ÙøĆĚÜêŠĂðŘ (Ùî) êĆüĀćø b = ÝĈîüîñĎšðśü÷đïćĀüćîìĊęöćøĆïïøĉÖćøøĆÖþćĔîēøÜó÷ćïćúĔîøĂï 1 ðŘđéĊ÷üÖĆî (Ùî) Ď øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ E10, E11, E12, E13, E14 êĆüĀćø E10, E11, E12, E13, E14 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöĎú ìčÖðŘĀøČĂðŘúąÙøĆĚÜ (êĆüßĊĚüĆéøć÷ðŘ) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÖøąìøüÜÿćíćøèÿč×, Service Plan ÿć×ćêć, Service Plan ÿć×ćēøÙĕöŠêĉéêŠĂđøČĚĂøĆÜ üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé 1 êčúćÙö 2559 đĀêčñú×ĂÜÖćøðøĆïðøčÜ ðøĆïðøčÜÙøĆĚÜìĊę 1 (êčúćÙö 2558): ðøĆïĒÖšĕ×ßČęĂõćþćĂĆÜÖùþ đóĉęöÙüćößĆéđÝî×ĂÜîĉ÷ćö ךĂöĎúìĊęÝĆéđÖĘï ðøĆïðøčÜÙøĆĚÜìĊę 2 (êčúćÙö 2559): êĆéîĉ÷ćö ÙĈüŠć “Principal diagnosis Ēúą/ĀøČĂ Pdx” ĂĂÖ đîČęĂÜÝćÖ ÖćøúÜøĀĆÿ ICD-10 ×ĂÜñĎšðśü÷îĂÖ Ĕîïøĉïìðøąđìýĕì÷ñĎšðśü÷ÝąöćøĆïÖćø øĆÖþćéšü÷ēøÙøŠüöĀúć÷ēøÙ ēé÷ĂćÝÝąĕöŠĕéšøąïčĔĀšđïćĀüćîđðŨîēøÙĀúĆÖđìŠćîĆĚî Āöć÷đĀêč G DC0103 Āöüé DC: Chronic Disease (C) ðøąđõì DC01 Diabetes Mellitus DC0103

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 93 ĀöüéêĆüßĊĚüĆé Chronic disease ðøąđõìêĆüßĊĚüĆé DM øĀĆÿêĆüßĊĚüĆé DC0107 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąñĎšðśü÷đïćĀüćîĕéšøĆïÖćøêé×ćÝćÖõćüąĒìøÖà Ć šĂî×ĂÜēøÙđïćĀüćî ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) DM: Percent of lower-extremity amputation among patients with diabetes îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷đïćĀüćî Āöć÷ëċÜ ñĎšðśü÷ìĆĚÜĔîÿëćîąñĎšðśü÷ĔîĒúąñĎšðśü÷îĂÖ Ăć÷č15 ðŘ×ċĚîĕð ìĊę öĊPrincipal diagnosis (pdx) đðŨîēøÙđïćĀüćî ĒúąđðŨîñĎšðśü÷ìĊę×ċĚîìąđïĊ÷îøĆïÖćøøĆÖþć ÖĆïēøÜó÷ćïćúàċęÜöćøĆïÖćøêøüÝêĉéêćöĔîÙúĉîĉÖ œ 2 ÙøĆĚÜĔî 6 đéČĂî ĀøČĂ œ 3 ÙøĆĚÜĔî 1 ðŘēé÷đðŨîēøÙìĊęöĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ÖćøêĆé×ćÝćÖõćüąĒìøÖàšĂî Āöć÷ëċÜ ÖćøìĊęñĎšðśü÷đïćĀüćîĕöŠÿćöćøëÙüïÙčöøąéĆï îĚĈêćúĔĀšĂ÷ĎŠĔîđÖèæŤĕéšÝîđÖĉéõćüąĒìøÖàšĂîìĊęđìšćàċęÜÝĈđðŨîêšĂÜĔĀšÖćøøĆÖþćēé÷ÖćøêĆé×ć 3. ñĎšðśü÷đïćĀüćîìĊęĕéšøĆïÖćøêĆé×ć Āöć÷ëċÜ ñĎšðśü÷đïćĀüćîìĊę×ċĚîìąđïĊ÷îøĆïÖćøøĆÖþć×ĂÜ ēøÜó÷ćïćúàċęÜöĊõćüąĒìøÖàšĂîÝîÝĈđðŨîêšĂÜêĆé×ć ēé÷îĆïøüöìĆĚÜøć÷ìĊęñŠćêĆéđĂÜĒúąøć÷ ìĊęÿŠÜĕðđóČęĂøĆïÖćøñŠćêĆéìĊę øó.ĂČęî (ÖøèĊñĎšðśü÷ìĊęĕéšøĆïÖćøÿŠÜêŠĂđóČęĂìĈÖćøñŠćêĆé ĔĀšîĆïđðŨî ÷ĂéñĎšðśü÷đïćĀüćîìĊęĕéšøĆïÖćøêĆé×ć ×ĂÜēøÜó÷ćïćú ñĎšÿŠÜ Refer ēé÷ĕöŠîĆïđðŨî÷Ăé×ĂÜ ēøÜó÷ćïćú ñĎšøĆï Refer öćđóČęĂìĈÖćøñŠćêĆé) üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñúĒúąÙüćöÿöïĎøèŤ×ĂÜÖćøéĒúø Ď ĆÖþćñĎšðśü÷ēøÙđïćĀüćî ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷đïćĀüćîìĕéĊę šøïÖćøê Ć Ćé×ćÝćÖõćüąĒìøÖàšĂî×ĂÜēøÙđïćĀüćîìĆĚÜĀöé êĆüĀćø b = ÝĈîüîñĎšðśü÷đïćĀüćîìĊę×ċĚîìąđïĊ÷îøĆïÖćøøĆÖþć×ĂÜēøÜó÷ćïćúìĆĚÜĀöé (ĔîđéČĂî đéĊ÷üÖĆî) øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = E10, E11, E12, E13, E14 and Procedure = 84.10 - 84.19 êĆüĀćø Pdx = E10, E11, E12, E13, E14 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂđéČĂîúąÙøĆĚÜ (êĆüßĊĚüĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜîšĂ÷ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÿðÿß. üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč G DC0107

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 94 ĀöüéêĆüßĊĚüĆé Chronic disease ðøąđõìêĆüßĊĚüĆé DM øĀĆÿêĆüßĊĚüĆé DC0108 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úą×ĂÜñĎšðśü÷đïćĀüćîñĎšĔĀâìŠ ĊęÙüïÙčöøąéĆïîĚĈêćúĔîđúČĂéĕéšéĊ ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) DM: Percent of good controlled of blood sugar in adult îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷đïćĀüćîñĎšĔĀ⊠Āöć÷ëċÜ ñĎšðśü÷Ăć÷č œ 18 ðŘĔîÿëćîąñĎšðśü÷îĂÖìĊęĕéšøĆïÖćø üĉîĉÝÞĆ÷ēøÙđïćĀüćî ĒúąđðŨîñĎšðśü÷ìĊę×ċĚîìąđïĊ÷îøĆïÖćøøĆÖþćÖĆïēøÜó÷ćïćú àċęÜöćøĆïÖćø êøüÝêĉéêćöêŠĂđîČęĂÜĔîēøÜó÷ćïćúĀøČĂđÙøČĂ׊ć÷ÿëćîó÷ćïćú œ 2 ÙøĆĚÜĔîøą÷ąßŠüÜđüúć 6 đéČĂî ĀøČĂ œ 3 ÙøĆĚÜĔîøĂï 1 ðŘìĊęñŠćîöć ēé÷đðŨîēøÙìĊęöĊøĀĆÿēøÙêćö ICD-10 TM, ICD10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ñĎšðśü÷đïćĀüćîñĎšĔĀâŠìĊęÙüïÙčöøąéĆïîĚĈêćúĔîđúČĂéĕéšéĊĀöć÷ëċÜñĎšðśü÷đïćĀüćîñĎšĔĀâŠìĊęöĊøąéĆï ñúÖćøêøüÝ HbA1c Ă÷ĎŠĔîøąéĆïìĊęÙüïÙčöĕéšêćöÖúčŠöĂć÷čĔîߊüÜđüúćìĊęðøąđöĉî éĆÜîĊĚ 2.1 ñĎšðśü÷đïćĀüćîñĎšĔĀâŠĂć÷č< 60 ðŘ: öĊÙŠćøąéĆï HbA1c ÙøĆĚÜúŠćÿčéõć÷Ĕî 6 éČĂî Œ 7 mg% 2.2 ñĎšðśü÷đïćĀüćîñĎšĔĀâŠĂć÷č œ 60 ðŘ: öĊÙŠćøąéĆï HbA1c ÙøĆĚÜúŠćÿčé Œ 8 mg% 3. êĆüßĊĚüĆéîĊĚöĊüĆêëčðøąÿÜÙŤđóČęĂÿŠÜđÿøĉöÙčèõćóÖćøêĉéêćöøąéĆïîĚĈêćúĔîđúČĂéêćö öćêøåćîēé÷ĔßšHbA1c ñŠćîÖúĕÖÖćøđìĊ÷ïđÙĊ÷ÜêĆüßĊĚüĆé ēé÷ĒîąîĈĔĀšêøüÝĂ÷ŠćÜîšĂ÷ðŘ úą 2 ÙøĆĚÜ ĀćÖĕöŠöĊñúÖćøêøüÝ HbA1c ÙøĆĚÜúŠćÿčéĔîߊüÜđüúć 6 đéČĂîìĊęðøąđöĉîêĉéêćö ĔĀš ÷ĆÜÙÜîĆïñĎšðśü÷øć÷ìĊęĕöŠðøćÖäñúÖćøêøüÝ HbA1c øüöĂ÷ĎŠĔîêĆüĀćø ĒúąĒðúñúêĆüêĆĚÜìĊęĕöŠ ðøćÖãñúêøüÝđðŨîñĎšðśü÷đïćĀüćîñĎšĔĀâŠìĊęÙüïÙčöøąéĆïîĚĈêćúĕéšĕöŠéĊ üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñú×ĂÜÖćøéĎĒúøÖþćÖú Ć čŠöñĎšðśü÷ēøÙđïćĀüćîñĎšĔĀ⊠ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷đïćĀüćîñĎšĔĀâìŠ ĊęÙüïÙčöøąéĆïîĚĈêćúĔîđúČĂéĕéšéêćöđÖèæ Ċ ŤìĊęÖĈĀîé ĔîߊüÜđüúć 6 đéČĂî (ÙøċęÜðŘ) êĆüĀćø b = ÝĈîüîñĎšðśü÷đïćĀüćîñĎšĔĀâìŠ Ċę×ċĚîìąđïĊ÷îøĆïÖćøøĆÖþćÖĆïēøÜó÷ćïćúĒúąöćøĆï ïøĉÖćøìĆĚÜĀöéĔîߊüÜđüúćÙøċęÜðŘđé÷üÖ Ċ Ćî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ E10, E11, E12, E13, E14 êĆüĀćø E10, E11, E12, E13, E14 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖ 6 đéČĂî (êĆüßĊĚüĆéøć÷ÙøċęÜðŘ) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÿöćÙöēøÙđïćĀüćîĒĀŠÜðøąđìýĕì÷ üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2564 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč G DC0108 G

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 95 ĀöüéêĆüßĊĚüĆé Chronic Disease ðøąđõìêĆüßĊĚüĆé DM øĀĆÿêĆüßĊĚüĆé DC0108.1 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úą×ĂÜñĎšðśü÷đïćĀüćîñĎšĔĀâĂć÷ Š čđÖĉîÖüŠć 60 ðŘìĊęÙüïÙčöøąéïîĆ ĚĈêćúĔîđúČĂéĕéšéĊ ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) DM: Percent of good controlled of blood sugar in adult aged œ 60 years old îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷đïćĀüćîñĎšĔĀâŠĂć÷čđÖĉîÖüŠć 60 ðŘĀöć÷ëċÜ ñĎšðśü÷ñĎšĔĀâŠĂć÷č œ 60 ðŘĔîÿëćîą ñĎšðśü÷îĂÖìĊęĕéšøĆïÖćøüĉîĉÝÞĆ÷ēøÙđïćĀüćî ĒúąđðŨîñĎšðśü÷ìĊę×ċĚîìąđïĊ÷îøĆïÖćøøĆÖþćÖĆï ēøÜó÷ćïćú àċęÜöćøĆïÖćøêøüÝêĉéêćöêŠĂđîČęĂÜĔîēøÜó÷ćïćúĀøČĂđÙøČĂ׊ć÷ÿëćîó÷ćïćú œ 2 ÙøĆĚÜĔîøą÷ąßŠüÜđüúć 6 đéČĂî ĀøČĂ œ 3 ÙøĆĚÜĔîøĂï 1 ðŘìĊęñŠćîöć ēé÷đðŨîēøÙìĊęöĊøĀĆÿ ēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ñĎšðśü÷đïćĀüćîñĎšĔĀâŠĂć÷čđÖĉîÖüŠć 60 ðŘìĊęÙüïÙčöøąéĆïîĚĈêćúĔîđúČĂéĕéšéĊĀöć÷ëċÜ ñĎšðśü÷đïćĀüćîñĎšĔĀ⊠Ăć÷č œ 60 ðŘìĊęöĊøąéĆïñúÖćøêøüÝ HbA1c ÙøĆĚÜúŠćÿčéõć÷Ĕî 6 đéČĂî Œ 8 mg% 3. êĆüßĊĚüĆéîĊĚöĊüĆêëčðøąÿÜÙŤđóČęĂÿŠÜđÿøĉöÙčèõćóÖćøêĉéêćöøąéĆïîĚĈêćúĔîđúČĂéêćö öćêøåćîēé÷ĔßšHbA1c ñŠćîÖúĕÖÖćøđìĊ÷ïđÙĊ÷ÜêĆüßĊĚüĆé ēé÷ĒîąîĈĔĀšêøüÝĂ÷ŠćÜîšĂ÷ðŘ úą 2 ÙøĆĚÜ ĀćÖĕöŠöĊñúÖćøêøüÝ HbA1c ÙøĆĚÜúŠćÿčéĔîߊüÜđüúć 6 đéČĂîìĊęðøąđöĉîêĉéêćö ĔĀš ÷ĆÜÙÜîĆïñĎšðśü÷øć÷ìĊęĕöŠðøćÖäñúÖćøêøüÝ HbA1c øüöĂ÷ĎŠĔîêĆüĀćø ĒúąĒðúñúêĆüêĆĚÜìĊęĕöŠ ðøćÖãñúêøüÝđðŨîñĎšðśü÷đïćĀüćîñĎšĔĀâŠìĊęÙüïÙčöøąéĆïîĚĈêćúĕéšĕöŠéĊ üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñú×ĂÜÖćøéĎĒúøÖþćÖú Ć čŠöñĎšðśü÷ñÿĎšĎÜĂć÷čìĊęđðŨîēøÙđïćĀüćî ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷đïćĀüćîñĎšĔĀâĂć÷ Š č œ 60 ðŘìĊęÙüïÙčöøąéĆïîĚĈêćúĔîđúČĂéĕééšĊêćö đÖèæŤìĊęÖĈĀîé ĔîߊüÜđüúć 6 đéČĂî (ÙøċęÜðŘ) êĆüĀćø b = ÝĈîüîñĎšðśü÷đïćĀüćîñĎšĔĀâĂć÷ Š č œ 60 ðŘìĊę×ċĚîìąđïĊ÷îøĆïÖćøøĆÖþćÖĆïēøÜó÷ćïćú ĒúąöćøĆïïøĉÖćøìĆĚÜĀöéĔîߊüÜđüúćÙøċęÜðŘđéĊ÷üÖĆî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ E10, E11, E12, E13, E14 êĆüĀćø E10, E11, E12, E13, E14 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖ 6 đéČĂî (êĆüßĊĚüĆéøć÷ÙøċęÜðŘ) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÿöćÙöēøÙđïćĀüćîĒĀŠÜðøąđìýĕì÷ üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2564 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč G DC0108.1 DC0108.1 G

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 96 ĀöüéêĆüßĊĚüĆé Chronic disease ðøąđõìêĆüßĊĚüĆé DM øĀĆÿêĆüßĊĚüĆé DC0108.2 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úą×ĂÜñĎšðśü÷đïćĀüćîñĎšĔĀâĂć÷ Š čîšĂ÷ÖüŠć 60 ðŘìĊęÙüïÙčöøąéïîĆ ĚĈêćúĔîđúČĂéĕéšéĊ ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) DM: Percent of good controlled of blood sugar in adult aged < 60 years old îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷đïćĀüćîñĎšĔĀâŠĂć÷čîšĂ÷ÖüŠć 60 ðŘĀöć÷ëċÜ ñĎšðśü÷ñĎšĔĀâŠĂć÷čđÖĉîÖüŠć 18 ðŘĒêŠ îšĂ÷ÖüŠć 60 ðŘĔîÿëćîąñĎšðśü÷îĂÖìĊęĕéšøĆïÖćøüĉîĉÝÞĆ÷ēøÙđïćĀüćî ĒúąđðŨîñĎšðśü÷ìĊę×ċĚî ìąđïĊ÷îøĆïÖćøøĆÖþćÖĆïēøÜó÷ćïćú àċęÜöćøĆïÖćøêøüÝêĉéêćöêŠĂđîČęĂÜĔîēøÜó÷ćïćúĀøČĂ đÙøČĂ׊ć÷ÿëćîó÷ćïćú œ 2 ÙøĆĚÜĔîøą÷ąßŠüÜđüúć 6 đéČĂî ĀøČĂ œ 3 ÙøĆĚÜĔîøĂï 1 ðŘìĊęñŠćî öć ēé÷đðŨîēøÙìĊęöĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ñĎšðśü÷đïćĀüćîñĎšĔĀâŠĂć÷čîšĂ÷ÖüŠć 60 ðŘìĊęÙüïÙčöøąéĆïîĚĈêćúĔîđúČĂéĕéšéĊĀöć÷ëċÜ ñĎšðśü÷đïćĀüćîñĎšĔĀâŠĂć÷čîšĂ÷ÖüŠć 60 ðŘìĊęöĊøąéĆïñúÖćøêøüÝ HbA1c ÙøĆĚÜúŠćÿčéõć÷Ĕî 6 đéČĂî Œ 7 mg% 3. êĆüßĊĚüĆéîĊĚöĊüĆêëčðøąÿÜÙŤđóČęĂÿŠÜđÿøĉöÙčèõćóÖćøêĉéêćöøąéĆïîĚĈêćúĔîđúČĂéêćö öćêøåćîēé÷ĔßšHbA1c ñŠćîÖúĕÖÖćøđìĊ÷ïđÙĊ÷ÜêĆüßĊĚüĆé ēé÷ĒîąîĈĔĀšêøüÝĂ÷ŠćÜîšĂ÷ðŘ úą 2 ÙøĆĚÜ ĀćÖĕöŠöĊñúÖćøêøüÝ HbA1c ÙøĆĚÜúŠćÿčéĔîߊüÜđüúć 6 đéČĂîìĊęðøąđöĉîêĉéêćö ĔĀš ÷ĆÜÙÜîĆïñĎšðśü÷øć÷ìĊęĕöŠðøćÖäñúÖćøêøüÝ HbA1c øüöĂ÷ĎŠĔîêĆüĀćø ĒúąĒðúñúêĆüêĆĚÜìĊęĕöŠ ðøćÖãñúêøüÝđðŨîñĎšðśü÷đïćĀüćîñĎšĔĀâŠìĊęÙüïÙčöøąéĆïîĚĈêćúĕéšĕöŠéĊ üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñú×ĂÜÖćøéĎĒúøÖþćÖú Ć čŠöñĎšðśü÷ñĎšĔĀâŠüĆ÷ìĈÜćîìĊęđðŨîēøÙđïćĀüćî ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷đïćĀüćîñĎšĔĀâĂć÷ Š čđÖĉîÖüŠć 18 ðŘĒêŠîšĂ÷ÖüŠć 60 ðŘìĊęÙüïÙčöøąéĆï îĚĈêćúĔîđúČĂéĕéšéêćöđÖèæ Ċ ŤìĊęÖĈĀîé ĔîߊüÜđüúć 6 đéČĂî (ÙøċęÜðŘ) êĆüĀćø b = ÝĈîüîñĎšðśü÷đïćĀüćîñĎšĔĀâĂć÷ Š čđÖĉîÖüŠć 18 ðŘĒêŠîšĂ÷ÖüŠć 60 ðŘìĊę×ċĚîìąđïĊ÷îøĆï ÖćøøĆÖþćÖĆïēøÜó÷ćïćúĒúąöćøïïø Ć ĉÖćøìĆĚÜĀöéĔîߊüÜđüúćÙøċęÜðŘđéĊ÷üÖĆî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ E10, E11, E12, E13, E14 êĆüĀćø E10, E11, E12, E13, E14 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖ 6 đéČĂî (êĆüßĊĚüĆéøć÷ÙøċęÜðŘ) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÿöćÙöēøÙđïćĀüćîĒĀŠÜðøąđìýĕì÷ üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2564 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč G DC0108.2 DC0108.2

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 97 ðøąđõì DC02 Hypertension ĀöüéêĆüßĊĚüĆé Chronic disease ðøąđõìêĆüßĊĚüĆé HT øĀĆÿêĆüßĊĚüĆé DC0201 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąñĎšðśü÷ÙüćöéĆîēúĀêÿĉ ĎÜìĊęÙüïÙčöÙüćöéĆîēúĀêĕé ĉ šéĊ ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) HT: Percent of good controlled of blood pressure îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ÙüćöéĆîēúĀĉêÿĎÜ Āöć÷ëċÜ ñĎšðśü÷Ăć÷č œ 18 ðŘĔîÿëćîąñĎšðśü÷îĂÖìĊęĕéšøĆïÖćø üĉîĉÝÞĆ÷ēøÙÙüćöéĆîēúĀĉêÿĎÜìĆĚÜìĊęđðŨîēøÙĀúĆÖĀøČĂēøÙøŠüö ĒúąđðŨîñĎšðśü÷ìĊę×ċĚîìąđïĊ÷îøĆï ÖćøøĆÖþćÖĆïēøÜó÷ćïćú àċęÜöćøĆïÖćøêøüÝêĉéêćöêŠĂđîČęĂÜĔîēøÜó÷ćïćúĀøČĂđÙøČĂ׊ć÷ ÿëćîó÷ćïćú œ 2 ÙøĆĚÜĔîøą÷ąßŠüÜđüúć 6 đéČĂî ĀøČĂ œ 3 ÙøĆĚÜĔîøĂï 1 ðŘìĊęñŠćîöć ēé÷ đðŨîēøÙìĊęöĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ñĎšðśü÷ÙüćöéĆîēúĀĉêÿĎÜìĊęÙüïÙčöøąéĆïÙüćöéĆîēúĀĉêĕéšéĊĀöć÷ëċÜ ñĎšðśü÷ēøÙÙüćöéĆî ēúĀĉêÿĎÜìĊęöĊñúÖćøêøüÝüĆéÙüćöéîēúĀ Ć ĉê×ĂÜñĎšðśü÷ÝćÖÖćøüĆéìĊęÿëćîó÷ćïćú Ă÷ĎŠĔîđÖèæŤ ÙüïÙčöêćöøąéĆïÙüćöéĆîēúĀĉêđðŜćĀöć÷ÖćøøĆÖþć ĔîߊüÜđüúćìĊęðøąđöĉî éĆÜîĊĚ 2.1 ñĎšðśü÷ÙüćöéĆîēúĀĉêÿĎÜ Ăć÷č < 65 ðŘ öĊñúÖćøüĆéÙüćöéĆîēúĀĉê 2 ÙøĆĚÜúŠćÿčéêĉéêŠĂÖĆî öĊÙŠć Œ 130/80 mmHg 2.2 ñĎšðśü÷ÙüćöéĆîēúĀĉêÿĎÜ Ăć÷č œ 65 ðŘ öĊñúÖćøüĆéÙüćöéĆîēúĀĉê 2 ÙøĆĚÜúŠćÿéêč ĉéêŠĂÖĆî öĊÙŠć Œ 140/80 mmHg üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñú×ĂÜÖćøéĎĒúøÖþćñ Ć Ďšðśü÷ēøÙÙüćöéĆîēúĀĉêÿĎÜ ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷ÙüćöéĆîēúĀêÿĉ ÜÙüïÙ Ď čöøąéïÙüćöé Ć ĆîēúĀĉêĕéšéêćöđÖèæ Ċ ŤìĊęÖĈĀîé ĔîߊüÜđüúć 6 đéČĂî (ÙøċęÜðŘ) êĆüĀćø b = ÝĈîüîñĎšðśü÷ÙüćöéĆîēúĀĉêÿÜìĎ Ċę×ċĚîìąđïĊ÷îøĆïÖćøøĆÖþćÖĆïēøÜó÷ćïćúĒúąöćøĆï ïøĉÖćøìĆĚÜĀöéĔîߊüÜđüúćÙøċęÜðŘđé÷üÖ Ċ Ćî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ I10, I11, I12, I13, I14, I15 êĆüĀćø I10, I11, I12, I13, I14, I15 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖ 6 đéČĂî (êĆüßĊĚüĆéøć÷ÙøċęÜðŘ) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÖøąìøüÜÿćíćøèÿč×, ĒîüìćÜÖćøøĆÖþćēøÙÙüćöéĆîēúĀĉêĔîđüßðäĉïĆêĉìĆęüĕð ó.ý. 2562 ÿöćÙöÙüćöéĆîēúĀêÿĉ ĎÜĒĀŠÜðøąđìýĕì÷ üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé 1 êčúćÙö 2564 đĀêčñú×ĂÜÖćøðøĆïðøčÜ ðøĆïðøčÜÙøĆĚÜìĊę 1 (êčúćÙö 2559): (1)êĆéîĉ÷ćöÙĈüŠć “principal diagnosis Ēúą/ĀøČĂ G DC0201

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 98 pdx” ĂĂÖ đîČęĂÜÝćÖ ÖćøúÜøĀĆÿ ICD-10 ×ĂÜñĎšðśü÷îĂÖ Ĕîïøĉïìðøąđìýĕì÷ñĎšðśü÷Ýąöć øĆïÖćøøĆÖþćéšü÷ēøÙøŠüöĀúć÷ēøÙ ēé÷ĂćÝÝąĕöŠĕéšøąïčĔĀšēøÙÙüćöéîēúĀ Ć êÿĉ ÜđðĎ ŨîēøÙĀúÖĆ đìŠćîĆĚî ðøĆïðøčÜÙøĆĚÜìĊę 2 (êčúćÙö 2564): ðøĆïîĉ÷ćöĔĀšÿĂéÙúšĂÜÖĆïĒîüìćÜÖćøøĆÖþćēøÙÙüćö éĆîēúĀĉêĔîđüßðäĉïĆêĉìĆęüĕð ó.ý. 2562 ÿöćÙöÙüćöéĆîēúĀĉêÿĎÜĒĀŠÜðøąđìýĕì÷ Āöć÷đĀêč

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 99 ĀöüéêĆüßĊĚüĆé Chronic disease ðøąđõìêĆüßĊĚüĆé HT øĀĆÿêĆüßĊĚüĆé DC0201.1 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąñĎšðśü÷ÙüćöéĆîēúĀêÿĉ ĎÜĂć÷čîšĂ÷ÖüŠć 65 ðŘìĊęÙüïÙčöÙüćöéîēúĀ Ć ĉêĕééšĊ ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) HT: Percent of good controlled of blood pressure of patient aged < 65 years old îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ÙüćöéĆîēúĀĉêÿĎÜĂć÷čîšĂ÷ÖüŠć 65 ðŘĀöć÷ëċÜ ñĎšðśü÷Ăć÷č œ 18 ðŘĒêŠ < 65 ðŘ Ĕî ÿëćîąñĎšðśü÷îĂÖìĊęĕéšøĆïÖćøüĉîĉÝÞĆ÷ēøÙÙüćöéĆîēúĀĉêÿĎÜìĆĚÜìĊęđðŨîēøÙĀúĆÖĀøČĂēøÙøŠüö ĒúąđðŨîñĎšðśü÷ìĊę×ċĚîìąđïĊ÷îøĆïÖćøøĆÖþćÖĆïēøÜó÷ćïćú àċęÜöćøĆïÖćøêøüÝêĉéêćöêŠĂđîČęĂÜ ĔîēøÜó÷ćïćúĀøČĂđÙøČĂ׊ć÷ÿëćîó÷ćïćú œ 2 ÙøĆĚÜĔîøą÷ąßŠüÜđüúć 6 đéČĂî ĀøČĂ œ 3 ÙøĆĚÜĔîøĂï 1 ðŘìĊęñŠćîöć ēé÷đðŨîēøÙìĊęöĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊę øąïčĕüšîĊĚ 2. ñĎšðśü÷ÙüćöéĆîēúĀĉêÿĎÜĂć÷čîšĂ÷ÖüŠć 65 ðŘìĊęÙüïÙčöøąéĆïÙüćöéĆîēúĀĉêĕéšéĊĀöć÷ëċÜ ñĎšðśü÷ēøÙÙüćöéĆîēúĀĉêÿĎÜìĊęöĊñúÖćøêøüÝüĆéÙüćöéĆîēúĀĉê×ĂÜñĎšðśü÷ÝćÖÖćøüĆéìĊę ÿëćîó÷ćïćú Ă÷ĎŠĔîđÖèæŤÙüïÙčöêćöøąéĆïÙüćöéĆîēúĀĉêđðŜćĀöć÷ÖćøøÖþć Ć ĔîߊüÜđüúć ìĊęðøąđöĉî éĆÜîĊĚ 2.1 ñĎšðśü÷ÙüćöéĆîēúĀĉêÿĎÜ Ăć÷č < 65 ðŘ öĊñúÖćøüĆéÙüćöéĆîēúĀĉê 2 ÙøĆĚÜúŠćÿčéêĉéêŠĂÖĆî öĊÙŠć Œ 130/80 mmHg üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñú×ĂÜÖćøéĎĒúøÖþćñ Ć Ďšðśü÷ēøÙÙüćöéĆîēúĀĉêÿĎÜ ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷ÙüćöéĆîēúĀêÿĉ ÜĎ Ăć÷č œ 18 ðŘĒêŠ < 65 ðŘìĊę×ċĚîìąđïĊ÷îøĆïÖćøøĆÖþćÖĆï ēøÜó÷ćïćúĒúąöćøĆïïøĉÖćø ìĊęÙüïÙčöøąéĆïÙüćöéĆîēúĀĉêĕéšéêćöđÖèæ Ċ ŤìĊęÖĈĀîé ĔîߊüÜ đüúć 6 đéČĂî (ÙøċęÜðŘ) êĆüĀćø b = ÝĈîüîñĎšðśü÷ÙüćöéĆîēúĀĉêÿÜĂć÷ Ď č œ 18 ðŘĒêŠ < 65 ðŘìĊę×ċĚîìąđïĊ÷îøĆïÖćøøĆÖþćÖĆï ēøÜó÷ćïćúĒúąöćøĆïïøĉÖćøìĆĚÜĀöéĔîߊüÜđüúćÙøċęÜðŘđéĊ÷üÖĆî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ I10, I11, I12, I13, I14, I15 êĆüĀćø I10, I11, I12, I13, I14, I15 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖ 6 đéČĂî (êĆüßĊĚüĆéøć÷ÙøċęÜðŘ) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÖøąìøüÜÿćíćøèÿč×, ĒîüìćÜÖćøøĆÖþćēøÙÙüćöéĆîēúĀĉêĔîđüßðäĉïĆêĉìĆęüĕð ó.ý. 2562 ÿöćÙöÙüćöéĆîēúĀêÿĉ ĎÜĒĀŠÜðøąđìýĕì÷ üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2564 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč G DC0201.1 DC0201.1 G

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 100 ĀöüéêĆüßĊĚüĆé Chronic disease ðøąđõìêĆüßĊĚüĆé HT øĀĆÿêĆüßĊĚüĆé DC0201.2 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąñĎšðśü÷ÙüćöéĆîēúĀêÿĉ ĎÜĂć÷čđÖĉîÖüŠć 65 ðŘìĊęÙüïÙčöÙüćöéîēúĀ Ć ĉêĕééšĊ ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) HT: Percent of good controlled of blood pressure of patient aged œ 65 years old îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ÙüćöéĆîēúĀĉêÿĎÜĂć÷čđÖĉîÖüŠć 65 ðŘĀöć÷ëċÜ ñĎšðśü÷Ăć÷č œ 65 ðŘĔîÿëćîąñĎšðü÷ś îĂÖìĊęĕéšøĆïÖćøüĉîĉÝÞĆ÷ēøÙÙüćöéĆîēúĀĉêÿĎÜìĆĚÜìĊęđðŨîēøÙĀúĆÖĀøČĂēøÙøŠüö ĒúąđðŨîñĎšðśü÷ìĊę ×ċĚîìąđïĊ÷îøĆïÖćøøĆÖþćÖĆïēøÜó÷ćïćú àċęÜöćøĆïÖćøêøüÝêĉéêćöêŠĂđîČęĂÜĔîēøÜó÷ćïćú ĀøČĂđÙøČĂ׊ć÷ÿëćîó÷ćïćú œ 2 ÙøĆĚÜĔîøą÷ąßŠüÜđüúć 6 đéČĂî ĀøČĂ œ 3 ÙøĆĚÜĔîøĂï 1 ðŘ ìĊęñŠćîöć ēé÷đðŨîēøÙìĊęöĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ñĎšðśü÷ÙüćöéĆîēúĀĉêÿĎÜĂć÷čđÖĉîÖüŠć 65 ðŘìĊęÙüïÙčöøąéĆïÙüćöéĆîēúĀĉêĕéšéĊĀöć÷ëċÜ ñĎšðśü÷ēøÙÙüćöéĆîēúĀĉêÿĎÜìĊęöĊñúÖćøêøüÝüĆéÙüćöéĆîēúĀĉê×ĂÜñĎšðśü÷ÝćÖÖćøüĆéìĊę ÿëćîó÷ćïćú Ă÷ĎŠĔîđÖèæŤÙüïÙčöêćöøąéĆïÙüćöéĆîēúĀĉêđðŜćĀöć÷ÖćøøÖþć Ć ĔîߊüÜđüúć ìĊęðøąđöĉî éĆÜîĊĚ 2.1 ñĎšðśü÷ÙüćöéĆîēúĀĉêÿĎÜ Ăć÷č œ 65 ðŘ öĊñúÖćøüĆéÙüćöéĆîēúĀĉê 2 ÙøĆĚÜúŠćÿčéêĉéêŠĂÖĆî öĊÙŠć Œ 140/80 mmHg üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñú×ĂÜÖćøéĎĒúøÖþćñ Ć Ďšðśü÷ēøÙÙüćöéĆîēúĀĉêÿĎÜ ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷ÙüćöéĆîēúĀêÿĉ ÜĎ Ăć÷č œ 18 ðŘĒêŠ < 65 ðŘìĊę×ċĚîìąđïĊ÷îøĆïÖćøøĆÖþćÖĆï ēøÜó÷ćïćúĒúąöćøĆïïøĉÖćø ìĊęÙüïÙčöøąéĆïÙüćöéĆîēúĀĉêĕéšéêćöđÖèæ Ċ ŤìĊęÖĈĀîé ĔîߊüÜ đüúć 6 đéČĂî (ÙøċęÜðŘ) êĆüĀćø b = ÝĈîüîñĎšðśü÷ÙüćöéĆîēúĀĉêÿÜĂć÷ Ď č œ 18 ðŘĒêŠ < 65 ðŘìĊę×ċĚîìąđïĊ÷îøĆïÖćøøĆÖþćÖĆï ēøÜó÷ćïćúĒúąöćøĆïïøĉÖćøìĆĚÜĀöéĔîߊüÜđüúćÙøċęÜðŘđéĊ÷üÖĆî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ I10, I11, I12, I13, I14, I15 êĆüĀćø I10, I11, I12, I13, I14, I15 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖ 6 đéČĂî (êĆüßĊĚüĆéøć÷ÙøċęÜðŘ) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÖøąìøüÜÿćíćøèÿč×, ĒîüìćÜÖćøøĆÖþćēøÙÙüćöéĆîēúĀĉêĔîđüßðäĉïĆêĉìĆęüĕð ó.ý. 2562 ÿöćÙöÙüćöéĆîēúĀêÿĉ ĎÜĒĀŠÜðøąđìýĕì÷ üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2564 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč G DC0201.2 DC0201.2 G

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 101 ðøąđõì DC03 HIV ĀöüéêĆüßĊĚüĆé Chronic disease ðøąđõìêĆüßĊĚüĆé HIV øĀĆÿêĆüßĊĚüĆé DC0301 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úą×ĂÜñêĎšĉéđßČĚĂđĂßĕĂüĊìĊęÖĉî÷ćêšćîĕüøĆÿ ĕéšøĆïÖćøêøüÝ Viral load (VL) Ă÷ŠćÜîšĂ÷ 1 ÙøĆĚÜêŠĂðŘ ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) HIV: Percent of people living with HIV with at least one test viral load (VL) after ARV treatment îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷/ñĎšêĉéđßČĚĂđĂßĕĂüĊĀöć÷ëċÜ ñĎšðśü÷ìĆĚÜĔîÿëćîąñĎšðśü÷îĂÖĒúąñĎšðśü÷Ĕî ìĊęöĊ Principal diagnosis (Pdx) đðŨîñĎšðśü÷/ñĎšìĊęöĊñúÖćøêøüÝüĉîĉÝÞĆ÷ēé÷öĊñúÖćøêøüÝđúČĂé ÷Čî÷ĆîĒúšüüŠć HIV positive ēé÷öĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ñĎšðśü÷/ñĎšêĉéđßČĚĂđĂßĕĂüĊìĊęÖĉî÷ćêšćîĕüøĆÿ Āöć÷ëċÜ ñĎšðśü÷/ñĎšêĉéđßČĚĂđĂßĕĂüĊìĊęÖĉî÷ćêšćî ĕüøĆÿÿĎêøĔéÿĎêøĀîċęÜöćîćîöćÖÖüŠć 6 đéČĂî 3. ñĎšðśü÷/ñĎšêĉéđßČĚĂđĂßĕĂüĊìĊęÖĉî÷ćêšćîĕüøĆÿ ĕéšøĆïÖćøêøüÝ VL Āöć÷ëċÜ ñĎšðśü÷/ñĎšêĉéđßČĚĂ đĂßĕĂüĊìĊęĕéšøĆïÖćøøĆÖþćéšü÷÷ćêšćîĕüøĆÿÿĎêøĔéÿĎêøĀîċęÜöćîćîöćÖÖüŠć 6 đéČĂî ĕéšøĆïÖćø êøüÝđúČĂéĀćÙŠćÝĈîüîđßČĚĂĕüøĆÿ Ă÷ŠćÜîšĂ÷ 1 ÙøĆĚÜêŠĂðŘ (ēé÷ñĎšðśü÷/ñĎšêĉéđßČĚĂđĂßĕĂüÖúĊ čŠöîĊĚ ÙüøĕéšøĆïÖćøêøüÝêĉéêćö VL ìčÖ 6-12đéČĂî) üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñúĒúąÙüćöÿöïĎøèŤ×ĂÜÖćøéĒúø Ď ĆÖþćñĎšðśü÷ēøÙHIV ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷/ñĎšêĉéđßČĚĂđĂßĕĂüĊìĊęĕéšøĆï÷ćêšćîĕüøĆÿĕéøšĆïÖćøêøüÝ VL Ă÷ŠćÜîšĂ÷ 1 ÙøĆĚÜ ĔîøĂï 1 ðŘ êĆüĀćø b = ÝĈîüîñĎšðśü÷/ñĎšêéđß ĉ ČĚĂđĂßĕĂüĊìĊęĕéšøĆïÖćøøĆÖþćéšü÷÷ćêćîĕüø š ÿîćîöćÖÖü Ć Šć 6 đéČĂî ìĆĚÜĀöé (ĔîðŘđéĊ÷üÖĆî) øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = B20, B21, B22, B23, B24, Z21 êĆüĀćø Pdx = B20, B21, B22, B23, B24, Z21 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖðŘĀøČĂðŘúąÙøĆĚÜ (êĆüßĊĚüĆéøć÷ðŘ) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference HIVQUAL-T üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč G DC0301

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 102 ĀöüéêĆüßĊĚüĆé Chronic disease ðøąđõìêĆüßĊĚüĆé HIV øĀĆÿêĆüßĊĚüĆé DC0302 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úą×ĂÜñêĎšĉéđßČĚĂđĂßĕĂüĊìĊęöĊViral load (VL) < 50 copies/ml ĀúĆÜÝćÖÖĉî÷ćêćîĕüø š ÿĆ öćĒúšü 12 đéČĂî ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) HIV: Percent of people living with HIV with viral load (VL) < 50 copies/ml after ARV treatment 12 months ago îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷/ ñĎšêĉéđßČĚĂđĂßĕĂüĊĀöć÷ëċÜ ñĎšðśü÷ìĆĚÜĔîÿëćîąñĎšðśü÷îĂÖĒúąñĎšðśü÷Ĕî ìĊęöĊ Principal diagnosis (Pdx) đðŨîñĎšðśü÷/ ñĎšìĊęöĊñúÖćøêøüÝüĉîĉÝÞĆ÷ēé÷öĊñúÖćøêøüÝđúČĂé ÷Čî÷ĆîĒúšüüŠć HIV positive ēé÷öĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ñĎšðśü÷/ ñĎšêĉéđßČĚĂđĂßĕĂüĊìĊęöĊVL < 50 copies/ml ĀúĆÜÝćÖÖĉî÷ćêšćîĕüøĆÿöćĒúšü 12 đéČĂî Āöć÷ëċÜ ñĎšðśü÷/ ñĎšêĉéđßČĚĂđĂßĕĂüĊìĊęĕéšøĆïÖćøøĆÖþćéšü÷ÖćøÖĉî÷ćêšćîĕüøĆÿÿĎêøĔé ÿĎêøĀîċęÜöćĒúšü 12 đéČĂî ĕéšøĆïÖćøêøüÝđúČĂéĀćÙŠćÝĈîüîđßČĚĂĕüøĆÿ (VL) ĒúšüóïüŠćöĊ ÙŠćîšĂ÷ÖüŠć 50 copies/ml üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñúĒúąÙüćöÿöïĎøèŤ×ĂÜÖćøéĒúø Ď ĆÖþćñĎšðśü÷ēøÙHIV ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷/ñĎšêĉéđßČĚĂđĂßĕĂüĊìĊęöĊVL < 50 copies/ml ĀúĆÜÝćÖÖĉî÷ćêšćîĕüøĆÿ öćĒúšü 12 đéČĂî êĆüĀćø b = ÝĈîüîñĎšðśü÷/ñĎšêéđß ĉ ČĚĂđĂßĕĂüĊìĊęđøĉęö÷ćêšćîĕüøĆÿÙøï 12 đéČĂîĔîߊüÜðŘìĊęðøąđöĉî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = B20, B21, B22, B23, B24, Z21 êĆüĀćø Pdx = B20, B21, B22, B23, B24, Z21 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖðŘĀøČĂðŘúąÙøĆĚÜ (êĆüßĊĚüĆéøć÷ðŘ) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference HIVQUAL-T üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč G DC0302

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 103 ĀöüéêĆüßĊĚüĆé Chronic Disease ðøąđõìêĆüßĊĚüĆé HIV øĀĆÿêĆüßĊĚüĆé DC0306 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úą×ĂÜñêĎšĉéđßČĚĂđĂßĕĂüĊđóýĀâĉÜĕéšøïÖćøÙ Ć éÖøĂÜöąđø Ć ĘÜðćÖöéúĎÖ ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) HIV: Percent of people living with HIV screening PAP smear îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷/ ñĎšêĉéđßČĚĂđĂßĕĂüĊĀöć÷ëċÜ ñĎšðśü÷ìĆĚÜĔîÿëćîąñĎšðśü÷îĂÖĒúąñĎšðśü÷Ĕî ìĊęöĊ Principal diagnosis (Pdx) đðŨîñĎšðśü÷/ ñĎšìĊęöĊñúÖćøêøüÝüĉîĉÝÞĆ÷ēé÷öĊñúÖćøêøüÝđúČĂé ÷Čî÷ĆîĒúšüüŠć HIV positive ēé÷öĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ÖćøÙĆéÖøĂÜöąđøĘÜðćÖöéúÖĎ Āöć÷ëċÜÖćøêøüÝēé÷üĉíĊÖćøìĈ Pap Smear ĀøČĂ visual inspection with acetic acid (VIA) ēé÷ñĎšðśü÷/ñĎšêĉéđßČĚĂđĂßĕĂüĊđóýĀâĉÜÙüøĕéšøĆïÖćø êøüÝĂ÷ŠćÜîšĂ÷ðŘúą 1 ÙøĆĚÜ üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñúĒúąÙüćöÿöïĎøèŤ×ĂÜÖćøéĒúø Ď ĆÖþćñĎšðśü÷ēøÙ HIV ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷/ñĎšêĉéđßČĚĂđĂßĕĂüĊđóýĀâĉÜìĊęĕéøšĆïÖćøÙéÖøĂÜöąđø Ć ĘÜðćÖöéúĎÖĂ÷ŠćÜîšĂ÷ 1 ÙøĆĚÜĔîðŘìĊęðøąđöĉî êĆüĀćø b = ÝĈîüîñĎšðśü÷/ñĎšêéđß ĉ ČĚĂđĂßĕĂüĊđóýĀâĉÜìĆĚÜĀöé (ĔîøĂïðŘìĊęðøąđöĉîđé÷üÖ Ċ Ćî) øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = B20, B21, B22, B23, B24, Z21 êĆüĀćø Pdx = B20, B21, B22, B23, B24, Z21 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖðŘĀøČĂðŘúąÙøĆĚÜ (êĆüßĊĚüĆéøć÷ðŘ) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference HIVQUAL-T üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đðŜćĀöć÷×ĂÜøąïï THIP Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * Āöć÷đĀêč G DC0306

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 104 ĀöüéêĆüßĊĚüĆé Chronic disease ðøąđõìêĆüßĊĚüĆé HIV øĀĆÿêĆüßĊĚüĆé DC0307 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úą×ĂÜñêĎšĉéđßČĚĂđĂßĕĂüøć÷ĔĀö Ċ ŠìĊęĕéøšĆïÖćøêøüÝÙéÖøĂÜēøÙà Ć ĉôŗúĉÿ ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) HIV: Percent of people living with HIV newly registered who were tested for syphilis îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷/ñĎšêĉéđßČĚĂđĂßĕĂüĊĀöć÷ëċÜ ñĎšðśü÷ìĆĚÜĔîÿëćîąñĎšðśü÷îĂÖĒúąñĎšðśü÷Ĕî ìĊęöĊ Principal diagnosis (Pdx) đðŨîñĎšðśü÷/ñĎšìĊęöĊñúÖćøêøüÝüĉîĉÝÞĆ÷ēé÷öĊñúÖćøêøüÝđúČĂé ÷Čî÷ĆîĒúšüüŠć HIV Positive ēé÷öĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ÖćøêøüÝÙĆéÖøĂÜàĉôŗúĉÿ öĊüĆêëčðøąÿÜÙŤđóČęĂêøüÝĀćēøÙàĉôŗúĉÿēé÷ÖćøêøüÝđúČĂé ÿćöćøëìĈĕéšēé÷ÖćøêøüÝđúČĂé (syphilis serologist screening tests) ðøąÖĂïéšü÷ ÖćøêøüÝ 2 ßîĉé ÙČĂ 2.1 Non-treponemal test : VDRL, RPR 2.2 Treponemal test : TPHA, TPPA, FTA-ABS üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñúĒúąÙüćöÿöïĎøèŤ×ĂÜÖćøéĒúø Ď ĆÖþćñĎšðśü÷/ñêĎšéđß ĉ ČĚĂ HIV ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷/ñĎšêĉéđßČĚĂđĂßĕĂüĊìøć÷ĔĀö Ċ Š ìĊęĕéøšĆïÖćøêøüÝÙéÖøĂÜēøÙà Ć ĉôŗúÿĉ ĔîøĂïðŘ øć÷Üćî êĆüĀćø b = ÝĈîüîñĎšðśü÷/ñĎšêéđß ĉ ČĚĂđĂßĕĂüĊøć÷ĔĀöŠìĆĚÜĀöé ĔîøĂïðøć÷Üćî Ř øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = B20, B21, B22, B23, B24, Z21, A51 êĆüĀćø Pdx = B20, B21, B22, B23, B24, Z21 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖðŘĀøČĂðŘúąÙøĆĚÜ (êĆüßĊĚüĆéøć÷ðŘ) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference HIVQUAL-T üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč G DC0307

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 105 ĀöüéêĆüßĊĚüĆé Chronic disease ðøąđõìêĆüßĊĚüĆé HIV øĀĆÿêĆüßĊĚüĆé DC0308 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úą×ĂÜñêĎšĉéđßČĚĂđĂßĕĂü/ĊđĂéÿìŤ ĊęĕéšøĆïÖćøøĆÖþćéšü÷÷ćêćîĕüø š Ćÿ è ðŦÝÝčïĆî ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) HIV: Percentage of people living with HIV who were currently receiving antiretroviral therapy îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšêĉéđßČĚĂđĂßĕĂüĊ/đĂéÿŤĀöć÷ëÜċñĎšðśü÷ìĆĚÜĔîÿëćîąñĎšðśü÷îĂÖĒúąñĎšðśü÷ĔîìĊęöñúĊ ÖćøêøüÝđúČĂé÷Čî÷ĆîĒúšüüŠć HIV positive öñúÖćøêøüÝü Ċ ĉîĉÝÞĆ÷ ēé÷đðŨîēøÙìĊęöøĀĊ Ćÿ ēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚĒúą×ċĚîìąđï÷îø Ċ ĆïÖćøøĆÖþćÖĆï ēøÜó÷ćïćú 2. ñĎšêĉéđßČĚĂđĂßĕĂüĊ/đĂéÿŤìĊęĕéøšĆïÖćøøĆÖþćéšü÷÷ćêšćîĕüøÿĆ Āöć÷ëċÜ ñĎšêĉéđßČĚĂđĂßĕĂ üĊ/đĂéÿŤìĊęÖĉî÷ćêšćîĕüøÿÿĆ êøĔéÿ Ď êøĀî Ď ċęÜĒúąöćøï÷ć Ć êøüÝêĉéêćöêŠĂđîČęĂÜĔî ēøÜó÷ćïćú œ 1 ÙøĆĚÜĔî 1 ðŘìĊęøć÷Üćî üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñúĒúąÙüćöÿöïĎøèŤ×ĂÜÖćøéĒúø Ď ĆÖþćñĎšðśü÷ēøÙ HIV ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšêĉéđßČĚĂđĂßĕĂüĊ/đĂéÿìŤ ĊęđךćëċÜ÷ćêšćîĕüøĆÿêćöîĉ÷ćöךà 2 êĆüĀćø B = ÝĈîüîñĎšðśü÷/ ñêĎšĉéđßČĚĂđĂßĕĂüĊìĆĚÜĀöéêćöîĉ÷ćöךà 1 øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ B20, B21, B22, B23, B24, Z21 êĆüĀćø B20, B21, B22, B23, B24, Z21 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖðŘĀøČĂðŘúąÙøĆĚÜ (êĆüßĊĚüĆéøć÷ðŘ) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * 75 (HIV HUB info Thailand / 2563) üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÖøąìøüÜÿćíćøèÿč×, ĒîüìćÜÖćøêøüÝøĆÖþćĒúąðŜĂÜÖĆîÖćøêéđß ĉ ĂđĂßĕĂü ČĚ Ċ ðøąđìýĕì÷ ðŘ2563-2564 üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2564 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč ÿćöćøëĂšćÜĂĉÜĕéšÝćÖøć÷ÜćîêĆüßĊĚüĆéĔîēðøĒÖøö NAP web report ÿðÿß. G DC0308

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 106 ĀöüéêĆüßĊĚüĆé Chronic disease ðøąđõìêĆüßĊĚüĆé HIV øĀĆÿêĆüßĊĚüĆé DC0309 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úą×ĂÜñêĎšĉéđßČĚĂđĂßĕĂüĊøć÷ĔĀöìŠ ĊęöĊךĂïŠÜßĊĚĔîÖćøøĆï÷ćðŜĂÜÖĆîüĆèēøÙ (Tuberculosis preventive therapy, TPT) ĕéšøĆï÷ć TPT ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) HIV: Percentage of newly diagnosed people living with HIV were receiving tuberculosis preventive therapy îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšêĉéđßČĚĂđĂßĕĂüĊøć÷ĔĀöŠ Āöć÷ëċÜ ñĎšêĉéđßČĚĂđĂßĕĂüĊìĊęĕéšøĆïÖćøüĉîĉÝÞ÷đð Ć ŨîÙøĆĚÜĒøÖ ĔîߊüÜðŘìĊęøć÷Üćî 2. ñĎšêĉéđßČĚĂđĂßĕĂüĊøć÷ĔĀööŠ ĊךĂïŠÜßĊĚĕéšĒÖŠñêĎšĉéđßČĚĂđĂßĕĂüĊøć÷ĔĀöŠìĊęĕöŠðśü÷đðŨîüĆè ēøÙ øŠüöÖĆïöĊCD4 < 200 cells/wL ĀøČĂ ĔîÖøèĊìĊę CD4 > 200 cells/wL öĊñú TST >5 öö. ĀøČĂ IGRA positive ĀøČĂĒóì÷ŤĒîąîĈĔĀšđøöÖćøø ĉę Ćï÷ćðŜĂÜÖĆîüĆè ēøÙēé÷ĕöŠÝĈđðŨîêšĂÜöĊñúêøüÝ 3. ñĎšêĉéđßČĚĂđĂßĕĂüĊøć÷ĔĀöĕéŠ øšĆïÖćøðŜĂÜÖĆîüĆèēøÙ (TPT) ēé÷ĕéšøĆïðøąìćî ÷ćĕĂ ēàĕîĂąàéĉ (Isoniazid) øŠüöÖĆï ĕøôćđóîìĉî (Rifapentine) ìčÖüĆîđðŨîđüúć 1 đéČĂî ĀøČĂìčÖÿĆðéćĀŤđðŨîđüúć 12 ÿĆðéćĀŤĀøČĂĕéøšĆï÷ćÿĎêøĂČęîė êćöĒîüìćÜ ðøąđìýđóČęĂðŜĂÜÖĆîÖćøðśü÷đðŨîüèēøÙ Ć õć÷Ĕî 6 đéČĂîĀúĆÜÝćÖøï÷ćê Ć šćîĕüøĆÿ HIVêćöĒîüìćÜÖćøêøüÝøĆÖþć ĒúąðŜĂÜÖĆîÖćøêéđß ĉ ČĚĂđĂßĕĂüĊðøąđìýĕì÷ ðŘ 2563/64 üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé đóČęĂðŜĂÜÖĆîÖćøđÖĉéüĆèēøÙøć÷ĔĀöŠ ĔîñĎšêĉéđßČĚĂđĂßĕĂüĊ ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ñĎšêĉéđßČĚĂđĂßĕĂüĊøć÷ĔĀöŠĕéšøĆï÷ćðŜĂÜÖĆîüĆèēøÙ (TPT) êĆüĀćø B = ñĎšêĉéđßČĚĂđĂßĕĂüĊøć÷ĔĀöŠìĊęöĊ×Ăïš ŠÜßĊĚ øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ B20, B21, B22, B23, B24, Z21 êĆüĀćø B20, B21, B22, B23, B24, Z21 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖðŘĀøČĂðŘúąÙøĆĚÜ (êĆüßĊĚüĆéøć÷ðŘ) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÖøąìøüÜÿćíćøèÿč×, ĒîüìćÜÖćøêøüÝøĆÖþćĒúąðŜĂÜÖĆîÖćøêéđß ĉ ĂđĂßĕĂü ČĚ Ċ ðøąđìýĕì÷ ðŘ2563-2564 üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2564 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč DC0309

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 107 ðøąđõì DC04 Cancer ĀöüéêĆüßĊĚüĆé Chronic disease ðøąđõìêĆüßĊĚüĆé Cancer øĀĆÿêĆüßĊĚüĆé DC0401 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąÖćøđÿĊ÷ßĊüĉê×ĂÜñĎšðśü÷ēøÙöąđøĘÜ ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Cancer: Percent of mortality îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷öąđøĘÜ (cancer) Āöć÷ëċÜ ñĎšðśü÷Ĕî (ñĎšðśü÷ìĊęøĆïĕüšîĂîóĆÖøĆÖþćĔîēøÜó÷ćïćúîćî êĆĚÜĒêŠ 4 ßĆęüēöÜ×ċĚîĕð) ìĊęöĊPrincipal diagnosis (Pdx) or Secondary diagnosis (Sdx) đðŨîēøÙöąđøĘÜ ēé÷öĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ÖćøđÿĊ÷ßĊüĉê×ĂÜñĎšðśü÷öąđøĘÜ (cancer) Āöć÷ëċÜ ÖćøđÿĊ÷ßĊüĉêÝćÖìčÖÿćđĀêč×ĂÜñĎšðśü÷ìĊęöĊ Pdx đðŨîöąđøĘÜ (cancer) ĀøČĂ Sdx đðŨîöąđøĘÜ ĒúąđÿĊ÷ßĊüĉêéšü÷ÿćđĀêčÝćÖ öąđøĘÜ 3. ÖćøÝĈĀîŠć÷ìčÖÿëćîą Āöć÷ëċÜ ÖćøìĊęñĎšðśü÷Ĕî ĂĂÖÝćÖēøÜó÷ćïćú ĔîìčÖÿëćîą ìčÖÖøèĊ üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñúĒúąÙüćöÿöïĎøèŤ×ĂÜÖćøéĒúø Ď ĆÖþćñĎšðśü÷ēøÙöąđøĘÜ ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîÙøĆĚÜ×ĂÜñĎšðśü÷öąđøĘÜìĊęÝĈĀîŠć÷éšü÷ÖćøđÿĊ÷ßĊüĉê Ĕî 1 đéĂîČ êĆüĀćø b = ÝĈîüîÙøĆĚÜ×ĂÜñĎšðśü÷öąđøĘÜìÝĈĀî Ċę Šć÷ìčÖÿëćîą (ĔîđéČĂîđéĊ÷üÖĆî) øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = C00-C97, D00-D09 ĀøČĂ Z51.0, Z51.1 and Sdx = C00-C97, D00-D09 êĆüĀćø Pdx = C00-C97, D00-D09 ĀøČĂ Z51.0, Z51.1 and Sdx = C00-C97, D00-D09 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂđéČĂîúąÙøĆĚÜ (êĆüßĊĚüĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜîšĂ÷ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÿðÿß. üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč G DC0401

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 108 ĀöüéêĆüßĊĚüĆé Chronic disease ðøąđõìêĆüßĊĚüĆé Cancer øĀĆÿêĆüßĊĚüĆé DC0402 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąÖćøøĆïÖúĆïđךćēøÜó÷ćïćúÖŠĂîüĆîîĆéēé÷ĕöĕéŠ šüćÜĒñî×ĂÜñĎšðśü÷öąđøĘÜ ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Cancer: Percent of unplanned re-admission îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷öąđøĘÜ (cancer) Āöć÷ëċÜ ñĎšðśü÷Ĕî (ñĎšðśü÷ìĊęøĆïĕüšîĂîóĆÖøĆÖþćĔîēøÜó÷ćïćú îćîêĆĚÜĒêŠ 4 ßĆęüēöÜ×ċĚîĕð) ìĊęöĊPrincipal diagnosis (Pdx) or Secondary diagnosis (Sdx) đðŨîēøÙöąđøĘÜ ēé÷öĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ÖćøøĆïÖúĆïđךćēøÜó÷ćïćúÖŠĂîüĆîîĆéēé÷ĕöŠĕéšüćÜĒñî×ĂÜñĎšðśü÷öąđøĘÜ (cancer) Āöć÷ëċÜ ÖćøìĊęñĎšðśü÷öąđøĘÜ (cancer) ÖúĆïöćøĆïÖćøêøüÝøĆÖþćÖŠĂîëċÜÖĈĀîéüĆîîĆéĀöć÷ ĒúąÝĈđðŨîêšĂÜøĆïÖúĆïđךćîĂîóĆÖøĆÖþćĔîēøÜó÷ćïćúēé÷ĕöŠĕéšüćÜĒñî üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñúĒúąÙüćöÿöïĎøèŤ×ĂÜÖćøéĒúø Ď ĆÖþćñĎšðśü÷ēøÙöąđøĘÜ ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîÙøĆĚÜ×ĂÜñĎšðśü÷öąđøĘÜìĊęöćêøüÝÖŠĂîëċÜÖĈĀîéüĆîîéĀöć÷Ēúąø Ć ĆïĕüšĔî ēøÜó÷ćïćú êĆüĀćø b = ÝĈîüîÙøĆĚÜ×ĂÜñĎšðśü÷öąđøĘÜìøĊę ĆïĕüšĔîēøÜó÷ćïćúìĆĚÜĀöé (ĔîđéĂîđé Č Ċ÷üÖĆî) øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = C00-C97, D00-D09 ĀøČĂ Z51.0, Z51.1 and Sdx = C00-C97, D00-D09 êĆüĀćø Pdx = C00-C97, D00-D09 ĀøČĂ Z51.0, Z51.1 and Sdx = C00-C97, D00-D09 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂđéČĂîúąÙøĆĚÜ (êĆüßĊĚüĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜîšĂ÷ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÿðÿß. üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč G DC0402

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 109 ĀöüéêĆüßĊĚüĆé Chronic disease ðøąđõìêĆüßĊĚüĆé Cancer øĀĆÿêĆüßĊĚüĆé DC0403 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąÖćøđÿĊ÷ßĊüĉêéšü÷ēøÙöąđøĘÜêĆï ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Liver Cancer: Percent of mortality îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷öąđøĘÜ (cancer) Āöć÷ëċÜ ñĎšðśü÷Ĕî (ñĎšðśü÷ìĊęøĆïĕüšîĂîóĆÖøĆÖþćĔîēøÜó÷ćïćú îćîêĆĚÜĒêŠ 4 ßĆęüēöÜ×ċĚîĕð) ìĊęöĊPrincipal diagnosis (Pdx) or Secondary diagnosis (Sdx) đðŨîēøÙöąđøĘÜ ēé÷öĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ÖćøđÿĊ÷ßĊüĉê×ĂÜñĎšðśü÷ Liver cancer Āöć÷ëċÜ ÖćøđÿĊ÷ßĊüĉêÝćÖìčÖÿćđĀêč×ĂÜñĎšðśü÷ Liver cancer ìĊęöĊPdx êćöìĊęøąïčĕüšĀøČĂñĎšðśü÷ìĊęöĊēøÙøŠüöĀøČĂēøÙĒìøÖđðŨîēøÙ Liver cancer ĒúąöĊÿćđĀêčÖćøêć÷ÝćÖēøÙēøÙ Liver cancer àċęÜĂ÷ĎŠĔîÿëćîąñĎšðśü÷Ĕî üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñúĒúąÙüćöÿöïĎøèŤ×ĂÜÖćøéĒúø Ď ĆÖþćñĎšðśü÷ēøÙöąđøĘÜêĆï ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîÙøĆĚÜ×ĂÜñĎšðśü÷ Liver cancer ìĊęÝĈĀîŠć÷éšü÷ÖćøđÿĊ÷ßĊüĉê Ĕî 1 đéČĂî êĆüĀćø b = ÝĈîüîÙøĆĚÜ×ĂÜñĎšðśü÷ Liver cancer ìĊęÝĈĀîŠć÷ìčÖÿëćîą (ĔîđéČĂîđéĊ÷üÖĆî) øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = C22.0, C22.2, C22.3, C22.4, C22.5, C22.6, C22.7, C22.8, C22.9 ĀøČĂ Pdx = Z51.0, Z51.1 and Sdx = C22.0, C22.2, C22.3, C22.4, C22.5, C22.6, C22.7, C22.8, C22.9 êĆüĀćø Pdx = C22.0, C22.2, C22.3, C22.4, C22.5, C22.6, C22.7, C22.8, C22.9 ĀøČĂ Pdx = Z51.0, Z51.1 and Sdx = C22.0, C22.2, C22.3, C22.4, C22.5, C22.6, C22.7, C22.8, C22.9 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂđéČĂîúąÙøĆĚÜ (êĆüßĊĚüĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜîšĂ÷ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÿðÿß. üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč G DC0403

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 110 ðøąđõì DC05 Chronic Kidney Disease ĀöüéêĆüßĊĚüĆé Chronic disease ðøąđõìêĆüßĊĚüĆé Chronic kidney disease (CKD) øĀĆÿêĆüßĊĚüĆé DC0501 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úą×ĂÜñĎšðśü÷ēøÙĕêđøČĚĂøĆÜìĊęÿćöćøëßąúĂÙüćöđÿČęĂö×ĂÜĕêĕéšêćöđðŜćĀöć÷ ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) CKD: Percent of patients who achieve the kidney function deterioration delayed target îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1) ñĎšðśü÷ēøÙĕêđøČĚĂøĆÜ (CKD) ìĊęÿćöćøëßąúĂÙüćöđÿČęĂö×ĂÜĕêĕéšêćöđðŜćĀöć÷ Āöć÷ëċÜ ñĎšðśü÷ēøÙĕêđøČĚĂøĆÜ (CKD) øą÷ąìĊę 3-4 ÿĆâßćêĉĕì÷ìĊęöćøĆïïøĉÖćøìĊęĒñîÖñĎšðśü÷îĂÖ×ĂÜ ēøÜó÷ćïćú ĒúąĕéšøĆïÖćøêøüÝ Serum Creatinine ēé÷öĊñú eGFR œ 2 ÙŠćĔîߊüÜđüúćìĊę êŠćÜÖĆî×ĂÜðŘìĊęđÖĘïךĂöĎú, ĒúąöĊÙŠćđÞúĊę÷ÖćøđðúĊę÷îĒðúÜ úéúÜ <4 ml/min/1.73 m2 /Yr 2) eGFR (estimated Glomerular Filtration Rate) Āöć÷ëċÜ ĂĆêøćÖćøÖøĂÜ×ĂÜĕêìĊęĕéš ÝćÖÖćøÙĈîüèÝćÖÙŠć Serum creatinine üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé đóČęĂĒÿéÜðøąÿĉìíĉñú ×ĂÜÖøąïüîÖćøßąúĂÙüćöđÿČęĂö×ĂÜĕêìĆĚÜøąïï ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷ēøÙĕêđøČĚĂøĆÜ (CKD) øą÷ąìĊę 3-4 ÿĆâßćêĉĕì÷ìĊęöćøĆïïøĉÖćøìĊęĒñîÖñĎšðśü÷ îĂÖ×ĂÜēøÜó÷ćïćú ĒúąĕéšøĆïÖćøêøüÝ Serum creatinine ēé÷öĊñú eGFR đÖĉîÖüŠć 2 ÙŠć ĔîߊüÜđüúćìĊęêŠćÜÖĆî×ĂÜðŘìĊęđÖĘïךĂöĎú, Ēúą öĊÙŠćđÞúĊę÷ÖćøđðúĊę÷îĒðúÜ úéúÜ <4 ml/min/1.73 m2 /Yr êĆüĀćø b = ÝĈîüîñĎšðśü÷ēøÙĕêđøČĚĂøĆÜ (CKD) øą÷ąìĊę 3-4 ÿĆâßćêĉĕì÷ìĊęöćøĆïïøĉÖćøìĊęĒñîÖñĎšðśü÷ îĂÖ×ĂÜēøÜó÷ćïćú ĒúąĕéšøĆïÖćøêøüÝ Serum Creatinine ēé÷öĊñú eGFR đÖĉîÖüŠć 2 ÙŠć ĔîߊüÜđüúćìĊęêŠćÜÖĆî×ĂÜðŘìĊęđÖĘïךĂöĎú øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ ñĎšðśü÷ÝćÖĒôŜö DIAGNOSIS OPD ìĊęöĊøĀĆÿēøÙđðŨî 1) N183, N184, (N189 ìĊęĕöŠöĊeGFR ĀøČĂöĊÙŠć eGFRœ15 ĒêŠîšĂ÷ÖüŠć 60 ml/min/1.73 m2 /Yr), 2) E102, E112, E122, E132, E142 ĀøČĂ I12*, I13*, I151 ìĊęöĊÙŠć eGFRœ15 ĒêŠîšĂ÷ÖüŠć 60 ml/min/1.73 m2 /Yr ēé÷îĆïÙîĕöŠàĚĈ ĒúąêšĂÜöĊñú eGFR đÖĉîÖüŠć 2 ÙŠć ĔîߊüÜđüúć ìĊęêŠćÜÖĆî×ĂÜðŘìĊęđÖĘïךĂöĎú, Ēúą öĊÙŠćđÞúĊę÷ÖćøđðúĊę÷îĒðúÜ úéúÜ <4 ml/min/1.73 m2 /Yr êĆüĀćø ñĎšðśü÷ÝćÖĒôŜö DIAGNOSIS_OPD ìĊęöĊøĀĆÿēøÙđðŨî 1) N183, N184, (N189 ìĊęĕöŠöĊeGFR ĀøČĂöĊÙŠć eGFR œ15 ĒêŠîšĂ÷ÖüŠć 60 ml/min/1.73 m2 /Yr), 2) E102, E112, E122, E132, E142 ĀøČĂ I12*, I13*, I151 ìĊęöĊÙŠć eGFRœ15 ĒêŠîšĂ÷ÖüŠć 60 ml/min/1.73 m2 /Yr ēé÷îĆïÙîĕöŠàĚĈ ĒúąêšĂÜöĊñú eGFR đÖĉîÖüŠć 2 ÙŠćĔîߊüÜđüúćìĊę êŠćÜÖĆî×ĂÜðŘìĊęđÖĘïךĂöĎú DC0501

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 111 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖ 1 ðŘ (êĆüßĊĚüĆéøć÷ðŘ) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * øšĂ÷úą 63 /ĂšćÜĂĉÜÝćÖ Health Data Center ÖøąìøüÜÿćíćøèÿč×/26 óùþõćÙö 2559 üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÖøöÖćøĒóì÷Ť/ ÿöćÙöēøÙĕêĒĀŠÜðøąđìýĕì÷ Ēúą Health Data Center ÖøąìøüÜ ÿćíćøèÿč× üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2559 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč G

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 112 ĀöüéêĆüßĊĚüĆé Chronic disease ðøąđõìêĆüßĊĚüĆé Chronic kidney disease (CKD) øĀĆÿêĆüßĊĚüĆé DC0502 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úą×ĂÜñĎšðśü÷ēøÙĕêđøČĚĂøĆÜìĊęĕéøšĆï÷ć ACEIs ĀøČĂ ARBs ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) CKD: Percent of patients who are receiving ACEIs or ARBs îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1) ñĎšðśü÷ēøÙĕêđøČĚĂøĆÜ (CKD) Āöć÷ëċÜ ñĎšðśü÷ìĊęĕéøšĆïÖćøüĉîĉÝÞ÷ēøÙĕêđø Ć ČĚĂøĆÜ (CKD) øą÷ąìĊę 1-4 ÿĆâßćêĉĕì÷ ìĊęöćøĆïïøĉÖćøìĊęĒñîÖñĎšðśü÷îĂÖ×ĂÜēøÜó÷ćïćú ĒúąĕéšøĆïÖćøêøüÝ Serum creatinine ēé÷öĊÙŠć eGFR œ15 ml/min/1.73 m2 /Yr 2) eGFR (estimated Glomerular Filtration Rate) Āöć÷ëċÜ ĂĆêøćÖćøÖøĂÜ×ĂÜĕêìĕéĊę š ÝćÖÖćøÙĈîüèÝćÖÙŠć Serum creatinine 3) ACEis Āöć÷ëċÜ ÷ćĔîÖúčŠö Angiotensin converting enzyme inhibitor 4) ARBs Āöć÷ëċÜ ÷ćĔîÖúčŠö Angiotensin receptor blocker üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé đóČęĂĒÿéÜðøąÿĉìíĉõćó ×ĂÜÖøąïüîÖćøéĎĒúøĆÖþćđóČęĂßąúĂÙüćöđÿČęĂö×ĂÜĕê×ĂÜĀîŠü÷ ïøĉÖćø ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷ēøÙĕêđøČĚĂøĆÜ (CKD) øą÷ąìĊę1-4 ÿĆâßćêĉĕì÷ ìĊęöćøĆïïøĉÖćøìĊęĒñîÖñĎšðśü÷ îĂÖ×ĂÜēøÜó÷ćïćú ĒúąĕéøšĆïÖćøêøüÝ Serum creatinine ēé÷öĊÙŠć eGFR œ15 ml/min/1.73 m2 /Yr, Ēúą ĕéøšĆïÖćøøĆÖþćéšü÷÷ć ACEi ĀøČĂ ARB êĆüĀćø b = ÝĈîüîñĎšðśü÷ēøÙĕêđøČĚĂøĆÜ (CKD) øą÷ąìĊę1-4 ÿĆâßćêĉĕì÷ ìĊęöćøĆïïøĉÖćøìĊęĒñîÖ ñĎšðśü÷îĂÖ×ĂÜēøÜó÷ćïćú ĒúąĕéšøĆïÖćøêøüÝ Serum creatinine ēé÷öÙĊŠć eGFR œ15 ml/min/1.73 m2 /Yr øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ ñĎšðśü÷ÝćÖĒôŜö DIAGNOSIS_OPD ìĊęöĊøĀĆÿēøÙđðŨî 1)N181, N182, N183, N184, (N189 ìĊęĕöŠöĊeGFR ĀøČĂöĊÙŠć eGFRœ15 ml/min/1.73 m2 /Yr), 2) E102, E112, E122, E132, E142 ĀøČĂ I12*, I13*, I151 ìĊęöĊÙŠć eGFRœ15 ml/min/1.73 m2 /Yr ēé÷îĆïÙîĕöŠàĚĈ Ēúą ĕéøšĆïÖćøøĆÖþćéšü÷÷ć ACEi ĀøČĂ ARB êĆüĀćø ñĎšðśü÷ÝćÖĒôŜö DIAGNOSIS_OPD ìĊęöĊøĀĆÿēøÙđðŨî 1)N181, N182, N183, N184, (N189 ìĊęĕöŠöĊeGFR ĀøČĂöĊÙŠć eGFRœ15 ml/min/1.73 m2 /Yr), 2) E102, E112, E122, E132, E142 ĀøČĂ I12*, I13*, I151 ìĊęöĊÙŠć eGFRœ15 ml/min/1.73 m2 /Yr ēé÷îĆïÙîĕöŠàĚĈ ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖ 6 đéČĂî (êĆüßĊĚüĆéøć÷ 6 đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * øšĂ÷úą 44 /ĂšćÜĂĉÜÝćÖ Health Data Center ÖøąìøüÜÿćíćøèÿč×/26 óùþõćÙö 2559 DC0502

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 113 üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÖøöÖćøĒóì÷/ Ť ÿöćÙöēøÙĕêĒĀÜðøąđìýĕì÷ Š Ēúą Health data center ÖøąìøüÜ ÿćíćøèÿč× üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2559 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč G

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 114 Āöüé DO: Musculoskeletal disease (O) ðøąđõì DO02 Hip ĀöüéêĆüßĊĚüĆé Musculoskeletal disease ðøąđõìêĆüßĊĚüĆé Hip øĀĆÿêĆüßĊĚüĆé DO0202 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úą×ĂÜñĎšðśü÷ñŠćêĆéđðúĊę÷îךĂÿąēóÖ ĕéšøĆï prophylactic antibiotic ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Hip arthroplasty: Percent of patients who received antibiotic prophylaxis in Hip arthroplasty îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ñŠćêĆéđðúĊę÷îךĂÿąēóÖ Āöć÷ëċÜ ñĎšðśü÷Ĕî (ñĎšðśü÷ìĊęøĆïĕüšîĂîóĆÖøĆÖþćĔî ēøÜó÷ćïćúîćîêĆĚÜĒêŠ 4 ßĆęüēöÜ×ċĚîĕð) ìĊęö Principal diagnosis (Pdx) Ċ đðŨîēøÙđÖĊę÷üÖĆïךà ÿąēóÖàċęÜÝĈđðŨîêšĂÜĔĀšÖćøøĆÖþćēé÷ÖćøñŠćêĆéđðúĊę÷îךĂÿąēóÖēé÷öĊøĀĆÿēøÙĂ÷ĎŠĔîÖúčŠö øĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ÖćøĕéšøĆï÷ćðäĉßĊüîąĒïïðŜĂÜÖĆîĔîÖćøñŠćêĆéđðúĊę÷îךĂÿąēóÖ Āöć÷ëċÜ ÖćøìĊęñĎšðśü÷ ĕéšøĆï÷ćðäĉßĊüîąĔîߊüÜøą÷ąđüúćõć÷Ĕî 1 ßĆęüēöÜÖŠĂîúÜöĊéñŠćêĆé (ÖøèĊđðŨîÖćøĔĀš÷ć Ēïï Intravenous drip ĔĀšđøĉęöîĆïđüúćđöČęĂ drip ÷ćĀöé) üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉõćóÖćøéĎĒúñĎšðü÷ñ ś ŠćêéĆ Hip arthroplasty ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîÙøĆĚÜ×ĂÜÖćøñŠćêĆéđðú÷î× Ċę šĂÿąēóÖìĊęĕéšøĆï prophylactic antibiotic õć÷Ĕî 1 ßĆęüēöÜ ÖŠĂîúÜöĊéñŠćêĆé Ĕî 1đéČĂî êĆüĀćø b = ÝĈîüîÙøĆĚÜ×ĂÜÖćøñŠćêéđðú Ć ÷î× Ċę šĂÿąēóÖìĆĚÜĀöéĔîđéČĂîđé÷üÖ Ċ Ćî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Procedure = 81.51, 81.52, 81.53 êĆüĀćø Procedure = 81.51, 81.52, 81.53 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference THIP I, http://www.aaos.org/about/papers/advistmt/1027.asp 2012 http://www.ashp.org/surgical-guidelines http://www.cdc.gov/HAI/pdfs/progress-report/hai-progress-report.pdf üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé 1 êčúćÙö 2558 đĀêčñú×ĂÜÖćøðøĆïðøčÜ ðøĆïðøčÜÙøĆĚÜìĊę1 (êčúćÙö 2558): ĔĀšêĆéøĀÿĆ ICD-9 81.40 ĂĂÖìĆĚÜĔîêĆüêĆĚÜĒúąêĆüĀćø đóČęĂĔĀšîĉ÷ćöÖćøÝéđÖ Ć ĘïÿĂéÙúšĂÜÖĆïîĉ÷ćöÿćÖú×ĂÜ CDC ìĊęøąïčüŠć HPRO Āöć÷ëċÜ 81.51, 81.52, 81.53 Āöć÷đĀêč G DO0202

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 115 ĀöüéêĆüßĊĚüĆé Musculoskeletal disease ðøąđõìêĆüßĊĚüĆé Hip øĀĆÿêĆüßĊĚüĆé DO0204 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąÖćøêéđß ĉ ČĚĂĒñúñŠćêĆéđðúĊę÷îךĂÿąēóÖõć÷Ĕî 1 ðŘ ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Hip arthroplasty: Percent of Hip arthroplasty associated infection within 1 Year îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ñŠćêĆéđðúĊę÷îךĂÿąēóÖ Āöć÷ëċÜ ñĎšðśü÷ìĆĚÜĔîÿëćîąñĎšðśü÷îĂÖĒúąñĎšðśü÷Ĕî ìĊęöĊ Principal diagnosis (Pdx) đðŨîēøÙđÖĊę÷üÖĆïךĂÿąēóÖ àċęÜÝĈđðŨîêšĂÜĔĀšÖćøøĆÖþćēé÷Öćø ñŠćêĆéđðúĊę÷îךĂÿąēóÖ ēé÷öĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. đðŨîÖćøêĉéđßČĚĂĔîךĂÿąēóÖĀúĆÜÖćøñŠćêĆéđðúĊę÷îךĂÿąēóÖ õć÷ĔîߊüÜøą÷ąđüúć 1 ðŘ ĀúĆÜÖćøñŠćêĆé îĆïđÞóćąÖćøêĉéđßČĚĂÙøĆĚÜĒøÖ üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîñúúĆóíŤ×ĂÜÖćøéĎĒúøĆÖþćñĎšðśü÷ìĊęöĊÖćøñŠćêĆéךĂÿąēóÖ ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîÙøĆĚÜ×ĂÜÖćøêĉéđßČĚĂĔîךĂÿąēóÖĀúĆÜÖćøñŠćêĆéđðúĊę÷îךĂÿąēóÖ êĆüĀćø b = ÝĈîüîÙøĆĚÜ×ĂÜÖćøñŠćêéđðú Ć ÷î× Ċę šĂÿąēóÖìĆĚÜĀöéĔîđéČĂîđé÷üÖ Ċ Ćî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Procedure = 81.51, 81.52, 81.53 Ēúą öĊÖćøêéđß ĉ ČĚĂ êĆüĀćø Procedure = 81.51, 81.52, 81.53 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜîšĂ÷ = öĊÙčèõćóéĊ ìĊęöć/ Reference THIP I , CDC, January 2014 üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé 1 êčúćÙö 2558 đĀêčñú×ĂÜÖćøðøĆïðøčÜ ðøĆïðøčÜÙøĆĚÜìĊę 1 (êčúćÙö 2558): ĔĀšêĆéøĀĆÿ ICD-9 81.40 ĂĂÖìĆĚÜĔîêĆüêĆĚÜĒúąêĆüĀćø đóČęĂĔĀšîĉ÷ćöÖćøÝĆéđÖĘïÿĂéÙúšĂÜÖĆïîĉ÷ćöÿćÖú×ĂÜ CDC ìĊęøąïčüŠć HPRO Āöć÷ëċÜ 81.51, 81.52, 81.53., (2) ðøĆïđóĉęöÙĈüŠć “õć÷Ĕî 1 ðŘ” êŠĂìšć÷ßČęĂêĆüßĊĚüĆé đóČęĂÙüćö ßĆéđÝî×ĂÜøą÷ąđüúćÖćøêĉéêćöÖćøêĉéđßČĚĂĔîߊüÜđüúć 1 ðŘ Āöć÷đĀêč G DO0204

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 116 ĀöüéêĆüßĊĚüĆé Musculoskeletal disease ðøąđõìêĆüßĊĚüĆé Hip øĀĆÿêĆüßĊĚüĆé DO0205 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąÖćøêéđß ĉ ČĚĂĒñúñŠćêĆéđðúĊę÷îךĂÿąēóÖõć÷Ĕî 90 üĆî ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Hip arthroplasty: Percent of Hip arthroplasty associated infection within 90 days îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ñŠćêĆéđðúĊę÷îךĂÿąēóÖ Āöć÷ëċÜ ñĎšðśü÷ìĆĚÜĔîÿëćîąñĎšðśü÷îĂÖĒúąñĎšðśü÷Ĕî ìĊęöĊ Principal diagnosis (Pdx) đðŨîēøÙđÖĊę÷üÖĆïךĂÿąēóÖ àċęÜÝĈđðŨîêšĂÜĔĀšÖćøøĆÖþćēé÷Öćø ñŠćêĆéđðúĊę÷îךĂÿąēóÖ ēé÷öĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. đðŨîÖćøêĉéđßČĚĂĔîךĂÿąēóÖĀúĆÜÖćøñŠćêĆéđðú÷î× Ċę šĂÿąēóÖ õć÷ĔîߊüÜøą÷ąđüúć 90 üĆî ĀúĆÜÖćøñŠćêĆé îĆïđÞóćąÖćøêĉéđßČĚĂÙøĆĚÜĒøÖ üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîñúúĆóíŤ×ĂÜÖćøéĎĒúøĆÖþćñĎšðśü÷ìĊęöĊÖćøñŠćêĆéךĂÿąēóÖìĊęÿćöćøëđìĊ÷ïđÙĊ÷ÜĕéšÖĆï CDC ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîÙøĆĚÜ×ĂÜÖćøêĉéđßČĚĂĔîךĂÿąēóÖĀúĆÜÖćøñŠćêĆéđðúĊę÷îךĂÿąēóÖ êĆüĀćø b = ÝĈîüîÙøĆĚÜ×ĂÜÖćøñŠćêéđðú Ć ÷î× Ċę šĂÿąēóÖìĆĚÜĀöéĔîđéČĂîđé÷üÖ Ċ Ćî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Procedure = 81.51, 81.52, 81.53 Ēúą öĊÖćøêéđß ĉ ČĚĂ êĆüĀćø Procedure = 81.51, 81.52, 81.53 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜîšĂ÷ = öĊÙčèõćóéĊ ìĊęöć/ Reference CDC, January 2014 üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2558 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč êćö CDC definition of HAI surveillance Ē÷Öøą÷ąđüúćÖćøêĉéêćöĂĂÖêćöÙüćöúċÖ ×ĂÜÖćøêĉéđßČĚĂ ëšćđðŨî Superficial SSI Ýąêćö 30 üĆî ëšćđðŨî deep SSI Ēúą organ/space SSI Ýąêćö 90 üĆî G DO0205

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 117 ðøąđõì DO03 Knee ĀöüéêĆüßĊĚüĆé Musculoskeletal disease ðøąđõìêĆüßĊĚüĆé Knee øĀĆÿêĆüßĊĚüĆé DO0302 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úą×ĂÜñĎšðśü÷ñŠćêĆéđðúĊę÷îךĂđ׊ć ĕéšøĆï prophylactic antibiotic ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Knee arthroplasty: Percent of patients who received antibiotic prophylaxis îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ñŠćêĆéđðúĊę÷îךĂđ׊ć Āöć÷ëċÜ ñĎšðśü÷Ĕî (ñĎšðśü÷ìĊęøĆïĕüšîĂîóĆÖøĆÖþćĔîēøÜó÷ćïćú îćîêĆĚÜĒêŠ4ßĆęüēöÜ×ċĚîĕð) ìĊęöĊ Principal diagnosis (Pdx) đðŨîēøÙđÖĊę÷üÖĆïךĂđ׊ćàċęÜ ÝĈđðŨîêšĂÜĔĀšÖćøøĆÖþćēé÷ÖćøñŠćêĆéđðúĊę÷îךĂđ׊ćēé÷öĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ÖćøĕéšøĆï÷ćðäĉßĊüîąĒïïðŜĂÜÖĆîĔîÖćøñŠćêĆéđðúĊę÷îךĂđ׊ć Āöć÷ëċÜ ÖćøìĊęñĎšðśü÷ĕéšøĆï ÷ćðäĉßĊüîąĔîߊüÜøą÷ąđüúćõć÷Ĕî 1 ßĆęüēöÜÖŠĂîúÜöĊéñŠćêĆé (ÖøèĊđðŨîÖćøĔĀš÷ćĒïï IV drip ĔĀšđøĉęöîĆïđüúćđöČęĂ drip ÷ćĀöé) üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉõćóÖćøéĎĒúñĎšðü÷ñ ś ŠćêéĆ Knee arthroplasty ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîÙøĆĚÜ×ĂÜÖćøñŠćêĆéđðú÷î× Ċę šĂđ׊ćìĊęĕéøšĆï prophylactic antibiotic õć÷Ĕî 1 ßĆęüēöÜ ÖŠĂîúÜöĊéñŠćêĆé Ĕî 1đéČĂî êĆüĀćø b = ÝĈîüîÙøĆĚÜ×ĂÜÖćøñŠćêéđðú Ć ÷î× Ċę šĂđ׊ćìĆĚÜĀöéĔîđéČĂîđéĊ÷üÖĆî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Procedure = 81.54, 81.55 êĆüĀćø Procedure = 81.54, 81.55 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference THIP I, 2012 http://www.ashp.org/surgical-guidelines http://www.cdc.gov/HAI/pdfs/progress-report/hai-progress-report.pdf üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé 1 êčúćÙö 2558 đĀêčñú×ĂÜÖćøðøĆïðøčÜ ðøĆïðøčÜÙøĆĚÜìĊę1 (êčúćÙö 2558): ĔĀšêĆéøĀÿĆ ICD-9 81.47 ĂĂÖìĆĚÜĔîêĆüêĆĚÜĒúąêĆüĀćø đóČęĂĔĀšîĉ÷ćöÖćøÝéđÖ Ć ĘïÿĂéÙúšĂÜÖĆïîĉ÷ćöÿćÖú×ĂÜ CDC ìĊęøąïčüŠć KPRO Āöć÷ëċÜ 81.54, 81.55 Āöć÷đĀêč ÖøèñĊŠćêĆéđ׊ćÿĂÜךćÜóøšĂöÖĆî îïđð Ć ŨîÖćøñŠćêĆé 1 ÙøĆĚÜ G DO0302

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 118 ĀöüéêĆüßĊĚüĆé Musculoskeletal disease ðøąđõìêĆüßĊĚüĆé Knee øĀĆÿêĆüßĊĚüĆé DO0303 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąÖćøêéđß ĉ ČĚĂĔîךĂđ׊ćĀúĆÜÖćøñŠćêéđðú Ć Ċę÷îךĂđ׊ćõć÷Ĕî 1 ðŘ ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Knee artrhoplasty: Percent of surgical infection within 1 year îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ñŠćêĆéđðúĊę÷îךĂđ׊ćĀöć÷ëċÜñĎšðśü÷Ĕî (ñĎšðśü÷ìĊęøĆïĕüšîĂîóĆÖøĆÖþćĔîēøÜó÷ćïćú îćîêĆĚÜĒêŠ 4 ßĆęüēöÜ×ċĚîĕð) ìĊęöĊ Principal diagnosis (Pdx) đðŨîēøÙđÖĊę÷üÖĆïךĂđ׊ćàċęÜ ÝĈđðŨîêšĂÜĔĀšÖćøøĆÖþćēé÷ÖćøñŠćêĆéđðúĊę÷îךĂđ׊ćēé÷öĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. đðŨîÖćøêĉéđßČĚĂĔîךĂđ׊ćĀúĆÜÖćøñŠćêĆéđðúĊę÷îךĂđ׊ć õć÷Ĕîøą÷ąđüúć 1 ðŘĀúĆÜÖćø ñŠćêĆéîĆïđÞóćąÖćøêĉéđßČĚĂÙøĆĚÜĒøÖ üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîñúúĆóíŤ×ĂÜÖćøéĎĒúøĆÖþćñĎšðśü÷ìĊęöĊÖćøñŠćêĆéđðúĊę÷îךĂđ׊ć ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîÙøĆĚÜ×ĂÜÖćøêĉéđßČĚĂĔîךĂđ׊ćĀúĆÜÖćøñŠćêĆéđðú÷î× Ċę šĂđ׊ć êĆüĀćø b = ÝĈîüîÙøĆĚÜ×ĂÜÖćøñŠćêéđðú Ć ÷î× Ċę šĂđ׊ćìĆĚÜĀöé øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Procedure = 81.54, 81.55 Ēúą öĊÖćøêéđß ĉ ČĚĂ êĆüĀćø Procedure = 81.54, 81.55 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜîšĂ÷ = öĊÙčèõćóéĊ ìĊęöć/ Reference THIP I ,CDC , January 2014, NSHN üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé 1 êčúćÙö 2558 đĀêčñú×ĂÜÖćøðøĆïðøčÜ ðøĆïðøčÜÙøĆĚÜìĊę 1 (êčúćÙö 2558): ĔĀšêĆéøĀĆÿ ICD-9 81.47 ĂĂÖìĆĚÜĔîêĆüêĆĚÜĒúąêĆüĀćø đóČęĂĔĀšîĉ÷ćöÖćøÝĆéđÖĘïÿĂéÙúšĂÜÖĆïîĉ÷ćöÿćÖú×ĂÜ CDC ìĊęøąïčüŠć KPRO Āöć÷ëċÜ 81.54, 81.55., (2) ðøĆïđóĉęöÙĈüŠć “õć÷Ĕî 1 ðŘ” êŠĂìšć÷ßČęĂêĆüßĊĚüĆé đóČęĂÙüćößĆéđÝî×ĂÜ øą÷ąđüúćÖćøêĉéêćöÖćøêĉéđßČĚĂĔîߊüÜđüúć 1 ðŘ Āöć÷đĀêč ÖøèñĊŠćêĆéđ׊ćÿĂÜךćÜóøšĂöÖĆî îïđð Ć ŨîÖćøñŠćêĆé 1 ÙøĆĚÜ G DO0303

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 119 ĀöüéêĆüßĊĚüĆé Musculoskeletal disease ðøąđõìêĆüßĊĚüĆé Knee øĀĆÿêĆüßĊĚüĆé DO0304 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąÖćøêéđß ĉ ČĚĂĔîךĂđ׊ćĀúĆÜÖćøñŠćêéđðú Ć Ċę÷îךĂđ׊ćõć÷Ĕî 90 üĆî ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Knee artrhoplasty: Percent of surgical infection within 90 days îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ñŠćêĆéđðúĊę÷îךĂđ׊ćĀöć÷ëċÜñĎšðśü÷Ĕî (ñĎšðśü÷ìĊęøĆïĕüšîĂîóĆÖøĆÖþćĔîēøÜó÷ćïćú îćîêĆĚÜĒêŠ 4 ßĆęüēöÜ×ċĚîĕð) ìĊęöĊPrincipal diagnosis (Pdx) đðŨîēøÙđÖĊę÷üÖĆïךĂđ׊ćàċęÜ ÝĈđðŨîêšĂÜĔĀšÖćøøĆÖþćēé÷ÖćøñŠćêĆéđðúĊę÷îךĂđ׊ćēé÷öĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. đðŨîÖćøêĉéđßČĚĂĔîךĂđ׊ćĀúĆÜÖćøñŠćêĆéđðúĊę÷îךĂđ׊ć õć÷Ĕîøą÷ąđüúć 90 üĆî ĀúĆÜÖćø ñŠćêĆéîĆïđÞóćąÖćøêĉéđßČĚĂÙøĆĚÜĒøÖ üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîñúúĆóíŤ×ĂÜÖćøéĎĒúøĆÖþćñĎšðśü÷ìĊęöĊÖćøñŠćêĆéđðúĊę÷îךĂđ׊ćìÿćöćøëđì Ċę Ċ÷ïđÙ÷Üĕé Ċ š ÖĆï CDC ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîÙøĆĚÜ×ĂÜÖćøêĉéđßČĚĂĔîךĂđ׊ćĀúĆÜÖćøñŠćêĆéđðú÷î× Ċę šĂđ׊ć êĆüĀćø b = ÝĈîüîÙøĆĚÜ×ĂÜÖćøñŠćêéđðú Ć ÷î× Ċę šĂđ׊ćìĆĚÜĀöé øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Procedure = 81.54, 81.55 Ēúą öĊÖćøêéđß ĉ ČĚĂ êĆüĀćø Procedure = 81.54, 81.55 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜîšĂ÷ = öĊÙčèõćóéĊ ìĊęöć/ Reference CDC , January 2014, NSHN üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2558 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč (1) êćö CDC definition of HAI surveillance Ē÷Öøą÷ąđüúćÖćøêĉéêćöĂĂÖêćöÙüćö úċÖ×ĂÜÖćøêĉéđßČĚĂ ëšćđðŨî superficial SSI Ýąêćö 30 üĆî ëšćđðŨî Deep SSI Ēúą organ/space SSI Ýąêćö 90 üĆî (2) ÖøèĊñŠćêéđ× Ć ŠćÿĂÜךćÜóøšĂöÖĆî îĆïđðŨîÖćøñŠćêĆé 1 ÙøĆĚÜ G DO0304

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 120 Āöüé DG: Gastrointestinal disease (G) ðøąđõì DG01 UGIH ĀöüéêĆüßĊĚüĆé Gastrointestinal disease ðøąđõìêĆüßĊĚüĆé UGIH øĀĆÿêĆüßĊĚüĆé DG0101 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąÖćøøĆïÖúĆïđךćēøÜó÷ćïćú×ĂÜñĎšðśü÷ Upper GI Hemorrhage õć÷Ĕî 28 üĆî ēé÷ ĕöŠĕéšüćÜĒñî ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Upper gastrointestinal hemorrhage (UGIH): Percent of unplanned re-admission into the hospital within 28 days after last discharge îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ UGIH Āöć÷ëċÜ ñĎšðśü÷Ĕî (ñĎšðśü÷ìĊęøĆïĕüšîĂîóĆÖøĆÖþćĔîēøÜó÷ćïćú îćî œ 4 ßĆęüēöÜ) ìĊęöĊPrincipal diagnosis (Pdx) đðŨîēøÙìĊęöĊđúČĂéĂĂÖĔîøąïïìćÜđéĉîĂćĀćø ÿŠüîïîēé÷öĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. đðŨîÖćøøĆïÖúĆïđךćēøÜó÷ćïćú×ĂÜñĎšðśü÷ēøÙ Upper GI hemorrhage õć÷Ĕî 28üĆî ēé÷ĕöŠĕéšüćÜĒñîĀúĆÜÝĈĀîŠć÷ĂĂÖÝćÖ øó. éšü÷ÿëćîąÖćøĂîčâćêĔĀšÖúĆïïšćî (status = improve) (÷ÖđüšîñĎšðśü÷ìĊęĕðøĆÖþćìĊęēøÜó÷ćïćúĂČęî ĀøČĂĕöŠ÷ĉî÷ĂöøĆïÖćøøĆÖþćêćöĒñî) üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñúĒúąÙüćöÿöïĎøèŤ×ĂÜÖćøéĒúø Ď ĆÖþćñĎšðśü÷ēøÙ Upper GI hemorrhage ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷ Upper GI hemorrhage ìĊęêšĂÜøĆïÖúĆïđךćēøÜó÷ćïćúēé÷ĕöŠĕéšüćÜĒñî õć÷Ĕî 28 üĆî ĀúĆÜĂĂÖÝćÖ øó. êĆüĀćø b = ÝĈîüîñĎšðśü÷ Upper GI hemorrhage ìĊęÝĈĀîŠć÷ ĔîđéČĂîÖĂîĀî Š šćîĆĚî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = K25.0, K25.1, K25.2, K25.4, K25.5, K25.6, K26.0, K26.1, K26.2, K26.4, K26.5, K26.6, K27.0, K27.1, K27.2, K27.4, K27.5, K27.6, K28.0, K28.1, K28.2, K28.4, K28.5, K28.6, K29.0, K92.0, K92.1, K92.2 êĆüĀćø Pdx = K25.0, K25.1, K25.2, K25.4, K25.5, K25.6, K26.0, K26.1, K26.2, K26.4, K26.5, K26.6, K27.0, K27.1, K27.2, K27.4, K27.5, K27.6, K28.0, K28.1, K28.2, K28.4, K28.5, K28.6, K29.0, K92.0, K92.1, K92.2 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜîšĂ÷ = öĊÙčèõćóéĊ ìĊęöć/ Reference THIP I üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč G DG0101

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 121 ĀöüéêĆüßĊĚüĆé Gastrointestinal disease ðøąđõìêĆüßĊĚüĆé UGIH øĀĆÿêĆüßĊĚüĆé DG0102 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øą÷ąđüúćüĆîîĂîđÞúĊę÷ñĎšðśü÷ Upper GI hemorrhage (UGIH) ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Upper gastrointestinal hemorrhage (UGIH): Average length of stay îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ UGIH Āöć÷ëċÜ ñĎšðśü÷Ĕî (ñĎšðśü÷ìĊęøĆïĕüšîĂîóĆÖøĆÖþćĔîēøÜó÷ćïćú (admit) îćî œ 4 ßĆęüēöÜ) ìĊęöĊPrincipal diagnosis (Pdx) đðŨîēøÙìĊęöĊđúČĂéĂĂÖĔîøąïïìćÜđéĉîĂćĀćø ÿŠüîïîēé÷öĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ÝĈîüîüĆîîĂîøüö×ĂÜñĎšðśü÷ UGIH Āöć÷ëċÜ ñúøüöÝĈîüîüĆî ìĊęñĎšðśü÷ UGIH îĂîóĆÖ øĆÖþćêĆüĔîēøÜó÷ćïćú îĆïêĆĚÜĒêŠüĆîìĊęøĆïĕüšĔîēøÜó÷ćïćú ÝîëċÜüĆîìĊęÝĈĀîŠć÷ (ìčÖ ÿëćîąÖćøÝĈĀîŠć÷) ĂĂÖÝćÖēøÜó÷ćïćú üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉõćóÖćøøĆÖþćñðĎš śü÷ēøÙ Upper GI hemorrhage ÿĎêøĔîÖćøÙĈîüè a/b ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ñúøüöøą÷ąđüúćüĆîîĂî×ĂÜñĎšðśü÷ Upper GI hemorrhage êĆüĀćø b = ÝĈîüîñĎšðśü÷ Upper GI Hemorrhage ìĊęÝĈĀîŠć÷ ĔîߊüÜđüúćîĆĚî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = K25.0, K25.1, K25.2, K25.4, K25.5, K25.6, K26.0, K26.1, K26.2, K26.4, K26.5, K26.6, K27.0, K27.1, K27.2, K27.4, K27.5, K27.6, K28.0, K28.1, K28.2, K28.4, K28.5, K28.6, K29.0, K92.0, K92.1, K92.2 êĆüĀćø Pdx = K25.0, K25.1, K25.2, K25.4, K25.5, K25.6, K26.0, K26.1, K26.2, K26.4, K26.5, K26.6, K27.0, K27.1, K27.2, K27.4, K27.5, K27.6, K28.0, K28.1, K28.2, K28.4, K28.5, K28.6, K29.0, K92.0, K92.1, K92.2 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé üĆî Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜîšĂ÷ = öĊÙčèõćóéĊ ìĊęöć/ Reference THIP I üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč G DG0102

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 122 ðøąđõì DG02 Appendix ĀöüéêĆüßĊĚüĆé Gastrointestinal disease ðøąđõìêĆüßĊĚüĆé Appendix øĀĆÿêĆüßĊĚüĆé DG0201 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąÖćøđÖéĕÿ ĉ šêĉęÜìąúčĔîñĎšðśü÷ēøÙĕÿšêĉęÜĂĆÖđÿï ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Acute appendicitis: Percent of abruption îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé ñĎšðśü÷ĕÿšêĉęÜìąúč Āöć÷ëċÜ ñĎšðśü÷Ĕî (ñĎšðśü÷ìĊęøĆïĕüšîĂîóĆÖøĆÖþćĔîēøÜó÷ćïćú îćî œ 4 ßĆęüēöÜ) ìĊęöĊPrincipal diagnosis (Pdx) đðŨîēøÙĕÿšêĉęÜĂĆÖđÿïđÞĊ÷ïóúĆîĒúąđÖĉé õćüąĒìøÖàšĂîöĊĒñúìąúčēé÷öĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉõćóÖćøøĆÖþćñðĎš śü÷ēøÙĕÿêšĉęÜĂĆÖđÿïđÞ÷ïóú Ċ Ćî ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷ēøÙĕÿšêĉęÜìąúč ìøĊę ĆïĕüšøĆÖþćĔîēøÜó÷ćïćú ĔîđéČĂîîĆĚî êĆüĀćø b = ÝĈîüîñĎšðśü÷ēøÙĕÿšêĉęÜĂĆÖđÿïđÞĊ÷ïóúĆî ìĊęøĆïĕüšøĆÖþćĔîēøÜó÷ćïćúìĆĚÜĀöé (ĔîđéČĂî đéĊ÷üÖĆî) øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = K35.2 êĆüĀćø Pdx = K35 ĀøČĂ K35.2, K35.3, K35.8 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜîšĂ÷ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÿðÿß. üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč G DG0201

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 123 ĀöüéêĆüßĊĚüĆé Gastrointestinal disease ðøąđõìêĆüßĊĚüĆé Appendix øĀĆÿêĆüßĊĚüĆé DG0202 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąÖćøđÿĊ÷ßĊüĉêÝćÖĕÿêšĉęÜĂĆÖđÿï ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Acute appendicitis: Percent of mortality îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ĕÿšêĉęÜĂĆÖđÿïđÞĊ÷ïóúĆî Āöć÷ëċÜ ñĎšðśü÷Ĕî (ñĎšðśü÷ìĊęøĆïĕüšîĂîóĆÖøĆÖþćĔî ēøÜó÷ćïćú îćî œ 4 ßĆęüēöÜ) ìĊęöĊPrincipal Öiagnosis (Pdx) đðŨîēøÙĕÿšêĉęÜĂĆÖđÿï đÞĊ÷ïóúĆî ēé÷öĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. ÖćøđÿĊ÷ßĊüĉê×ĂÜñĎšðśü÷ĕÿšêĉęÜĂĆÖđÿïđÞĊ÷ïóúĆî Āöć÷ëċÜ ÖćøđÿĊ÷ßĊüĉêÝćÖìčÖÿćđĀêč×ĂÜ ñĎšðśü÷ĕÿšêĉęÜĂĆÖđÿïđÞĊ÷ïóúĆî 3. ÖćøÝĈĀîŠć÷ìčÖÿëćîą Āöć÷ëċÜÖćøìĊęñĎšðśü÷Ĕî ĂĂÖÝćÖēøÜó÷ćïćúĔîìčÖÿëćîą ìčÖÖøèĊ üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉõćóÖćøøĆÖþćñðĎš śü÷ēøÙĕÿêšĉęÜĂĆÖđÿïđÞ÷ïóú Ċ Ćî ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîÙøĆĚÜ×ĂÜñĎšðśü÷ĕÿêšĉęÜĂĆÖđÿïđÞ÷ïóú Ċ Ćî ìĊęÝĈĀîŠć÷éšü÷ÖćøđÿĊ÷ßĊüĉê ĔîđéČĂîîĆĚî êĆüĀćø b = ÝĈîüîÙøĆĚÜ×ĂÜñĎšðśü÷ĕÿšêĉęÜĂĆÖđÿïđÞ÷ïóú Ċ Ćî ìĊęÝĈĀîŠć÷ìčÖÿëćîą (ĔîđéČĂîđéĊ÷üÖĆî) øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = K35 ĀøČĂ K35.2, K35.3, K35.8 êĆüĀćø Pdx = K35 ĀøČĂ K35.2, K35.3, K35.8 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜîšĂ÷ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÿðÿß. üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2557 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč G DG0202

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 124 ĀöüéêĆüßĊĚüĆé Pediatric disease ðøąđõìêĆüßĊĚüĆé Diabetes in child and adolescent øĀĆÿêĆüßĊĚüĆé DP0101 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úą×ĂÜñĎšðśü÷đïćĀüćîßîĉéìĊę1 ĔîđéĘÖĒúąüĆ÷øčŠîĂć÷čîšĂ÷ÖüŠć 18 ðŘìĊęÙüïÙčöøąéĆï îĚĈêćúĕéšéĊ ßČęĂêĆüßĊĚüéĆ (õćþćĂĆÜÖùþ) Diabetes in child and adolescent: Percent of good controlled of blood sugar (age < 18 years) îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷đïćĀüćîßîĉéì 1 Ċę ĔîđéĘÖĒúąüĆ÷øčŠîìĊęĂć÷čîšĂ÷ÖüŠć 18 ðŘĀöć÷ëċÜ ñĎšðśü÷ìĊęĕéšøĆï ÖćøüĉîĉÝÞĆ÷üŠćđðŨîđïćĀüćîßîĉéì 1 Ċę ìĊęĂć÷čîšĂ÷ÖüŠć 18 ðŘđðŨîñĎšðśü÷ìĊę×ċĚîìąđïĊ÷îøĆïÖćø øĆÖþćÖĆïēøÜó÷ćïćú àċęÜöćøïÖćøêøüÝê Ć ĉéêćöêŠĂđîČęĂÜĔîēøÜó÷ćïćúĀøČĂđÙøČĂ׊ć÷ ÿëćîó÷ćïćú > 1 ÙøĆĚÜ ĔîߊüÜđüúć 6 đéČĂî ĀøČĂ > 3 ÙøĆĚÜĔîøĂï 1 ðŘìĊęñŠćîöć ēé÷đðŨî ēøÙìĊęöøĀĊ ĆÿēøÙêćö ICD -10 TM, ICD-10,ICD-9 ìĊęøąïčĕüšîĊĚ 2. ñĎšðśü÷đïćĀüćîßîĉéì 1 Ċę ĔîđéĘÖĒúąüĆ÷øčŠîĂć÷čîšĂ÷ÖüŠć 18 ðŘìĊęÙüïÙčöøąéĆïîĚĈêćúĕéšéĊ Āöć÷ëċÜñĎšðśü÷ìĊęöøąé Ċ ĆïñúÖćøêøüÝ HbA1CđÞú÷Ĕî Ċę 1 ðŘ < 7.5 % 3. êĆüßĊĚüĆéîĊĚöĊüĆêëčðøąÿÜÙŤđóČęĂÿŠÜđÿøĉöÙčèõćóÖćøêĉéêćöøąéĆïîĚĈêćúĔîđúČĂéêćö öćêøåćîēé÷Ĕßš HbA1C ñŠćîÖúĕÖÖćøđìĊ÷ïÙĊ÷ÜêĆüßĊĚüĆé ēé÷ĒîąîĈĔĀšêøüÝĂ÷ŠćÜîšĂ÷ ðŘ úą 2 ÙøĆĚÜ ĀćÖĕöŠöĊñúÖćøêøüÝ HbA1c ÙøĆĚÜúŠćÿčéĔîߊüÜđüúć 6 đéČĂîìĊęðøąđöĉîêĉéêćö ĔĀš ÷ĆÜÙÜîĆïñĎšðśü÷øć÷ìĊęĕöŠðøćÖäñúÖćøêøüÝ HbA1c øüöĂ÷ĎŠĔîêĆüĀćø ĒúąĒðúñúêĆüêĆĚÜìĊęĕöŠ ðøćÖãñúêøüÝđðŨîñĎšðśü÷đïćĀüćîßîĉéìĊę 1 ĔîđéĘÖĒúąüĆ÷øčŠîìĊęĂć÷čîšĂ÷ÖüŠć 18 ðŘìĊę ÙüïÙčöøąéĆïîĚĈêćúĕéšĕöŠéĊ üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñú×ĂÜÖćøéĎĒúøÖþćÖú Ć čŠöñĎšðśü÷ēøÙđïćĀüćîđïćĀüćîßîĉéì 1 Ċę ĔîđéĘÖ ĒúąüĆ÷øčŠîìĊęĂć÷čîšĂ÷ÖüŠć 18 ðŘ ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷đïćĀüćîđïćĀüćîßîĉéì 1 Ċę ĔîđéĘÖĒúąüĆ÷øčŠîìĊęĂć÷čîšĂ÷ÖüŠć 18 ðŘìĊę ÙüïÙčöøąéĆïîĚĈêćúĔîđúČĂéĕéšéêćöđÖèæ Ċ ŤìĊęÖĈĀîé ĔîߊüÜđüúćĀîÜðċę Ř êĆüĀćø b = ÝĈîüîñĎšðśü÷đïćĀüćîđïćĀüćîßîĉéì 1 Ċę ĔîđéĘÖĒúąüĆ÷øčŠîìĊęĂć÷čîšĂ÷ÖüŠć 18 ðŘìĊę×ċĚî ìąđïĊ÷îøĆïÖćøøĆÖþćÖĆïēøÜó÷ćïćúĒúąöćøïïø Ć ĉÖćøìĆĚÜĀöéĔîߊüÜðŘđéĊ÷üÖĆî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ E10, P70.2, E89.1 êĆüĀćø E10, P70.2, E89.1 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖ 1 ð (ŘêĆüßĊĚüĆéøć÷ðŘ) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * Dejkhamron P., Likitmaskul S., Deerochanawong C., Santiprabhob J., Tharavanij T.,et al. Outcomes of Type 1 Diabetes management and outcomes: a multicenter study in Thailand. J Diabetes Investig.2020 Aug 19. doi:10.1111/jdi.13390 online ahead of print. Figure1 ,P520 üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ G DP0101

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 125 ìĊęöć/ Reference đÙøČĂ׊ć÷ïøĉïćúđïćĀüćîßîĉéìĊę1 ĒúąÖćøúÜìąđïĊ÷îđïćĀüćîÖĂîĂć÷ Š č30 ðŘðøąđìý ĕì÷ (T1DDAR CN), ÿöćÙöēøÙđïćĀüćîĒĀŠÜðøąđìýĕì÷, ĒúąÿöćÙöêŠĂöĕøšìŠĂđéĘÖĒúąüĆ÷øîĕì÷ čŠ üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2564 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 126 Āöüé DS: Substance use disorder (S) ðøąđõì DS01 Methamphetamine group ĀöüéêĆüßĊĚüĆé Substance use disorder ðøąđõìêĆüßĊĚüĆé Methamphetamine group øĀĆÿêĆüßĊĚüĆé DS0101 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úą×ĂÜñêĎšĉé÷ćđÿóêĉéÖúčŠö Methamphetamine ēé÷øüöìĊęĀ÷éđÿóê č ŠĂđîČęĂÜ 3 đéČĂî ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Methamphetamine group: 3 months total remission rate îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé ñĎšêĉé÷ćđÿóêĉéÖúčŠö Methamphetamine Āöć÷ëċÜ ñĎšêé÷ćđÿóê ĉ ĉéÖúčŠö Methamphetamine đߊî ÷ćïšć ÷ćĕĂàŤ÷ćĂĊĒúą÷ćđúĉô đðŨîêšî Ā÷čéđÿóêŠĂđîČęĂÜ 3 đéČĂî Āöć÷ëÜċñĎšêĉé÷ćđÿóêéÖú ĉ čŠö Methamphetamine ìĊęđךćøĆïÖćø ïĈïĆéøĆÖþćĔîøąïïÿöĆÙøĔÝ ĒïïñĎšðśü÷îĂÖĒúąĕöÙøïđÖèæ Š ŤĔîÖćøüĉîĉÝÞĆ÷ ñêĎšĉé (dependence) êŠĂđîČęĂÜ 3 đéČĂîĀúĆÜÝĈĀîŠć÷ÝćÖÖćøïĈïéøĆ ĆÖþć ìĆĚÜîĊĚĕöŠøüöñĎšðśü÷ëĎÖ ÝĆïđÿĊ÷ßĊüĉê ĀøČĂÿŠÜêŠĂ ĀúĆÜÝĈĀîć÷ÝćÖÖćøïĈï Š éøĆ ĆÖþć üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîñúÖćøïĈïéøĆ ĆÖþćñĎšêĉé÷ćđÿóêéÖú ĉ čŠö Methamphetamine ĔîéšćîÖćøđÿøĉöóúĆÜ ĔĀöćø š ĆïÖćøêĉéêćöĒúąĀ÷éđÿóê č ŠĂđîČęĂÜ ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšêĉé÷ćđÿóêĉéÖúöčŠ Methamphetamine ìĊęĀ÷éđÿóê č Ăđî Š ČęĂÜ 3 đéČĂîĀúĆÜ ÝĈĀîŠć÷ÝćÖÖćøïĈïĆéøĆÖþć êĆüĀćø b = ÝĈîüîñĎšêĉé÷ćđÿóêĉéÖúčŠö Methamphetamine ìĊęđךćøïÖćøïĈï Ć ĆéøĆÖþćĔîøąïï ÿöĆÙøĔÝ ĒïïñĎšðśü÷îĂÖ ìĊęÝĈĀîŠć÷ÝćÖÖćøïĈïéøĆ ĆÖþćìĆĚÜĀöéĔîĕêøöćÿÖŠĂîĀîćš øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ F15.0-F15.9 êĆüĀćø F15.0-F15.9 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖ 3 đéČĂî ĀøČĂ ìčÖĕêøöćÿ (êĆüßĊĚüĆéøć÷ĕêøöćÿ) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * åćîךĂöĎúÖćøïĈïĆéøĆÖþć÷ćđÿóêĉé×ĂÜðøąđìý (ÖøąìøüÜÿćíćøèÿč×) üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÿëćïĆîïĈïĆéøĆÖþćĒúąôŚŪîôĎñĎšêé÷ćđÿóê ĉ éĒĀ ĉ ŠÜßćêĉïøöøćßßîîĊĒúąēøÜó÷ćïćúíââć Ć øĆÖþŤõĎöĉõćÙ üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2558 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč 2. êĆüĂ÷ŠćÜÖćøøć÷ÜćîñúÖćøéĈđîĉîÜćîĕêøöćÿìĊę 1 (1 ê.Ù.-31 í.Ù.) ĔßšåćîךĂöĎúñĎšðśü÷ìĊęÝĈĀîŠć÷ÝćÖ ÖćøïĈïĆéøĆÖþćìčÖÖøèĊìĆĚÜÙøïđÖèæŤÖĈĀîéĒúąĕöŠÙøïđÖèæŤÖĈĀîé(÷ÖđüšîëĎÖÝĆïđÿĊ÷ßĊüĉêĀøČĂ ÿŠÜêŠĂ) ĔîĕêøöćÿÖŠĂîĀîšć (1 Ö.Ù.–30 Ö.÷.) ĒúšüĀ÷čéđÿóêŠĂđîČęĂÜ 3 đéČĂî ĔîĀšüÜ 1 ê.Ù.-31 í.Ù. G DS0101

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 127 ðøąđõì DS02 Alcohol droup ĀöüéêĆüßĊĚüĆé Substance use disorders ðøąđõìêĆüßĊĚüĆé Alcohol group øĀĆÿêĆüßĊĚüĆé DS0201 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úą×ĂÜñêĎšĉéÿčøćēé÷øüö ìĊęĀ÷éđÿóê č ŠĂđîČęĂÜ 3 đéČĂî ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Alcohol group: 3 months total remission rate îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé ñĎšêĉéÿčøć Āöć÷ëċÜ ñĎšðśü÷êĉéÿćøđÿóêĉéÖúčŠöĒĂúÖĂăĂúŤđߊî ÿčøć đïĊ÷øŤđĀúšć×ćü ĄúĄ Ā÷čéđÿóêŠĂđîČęĂÜ 3 đéČĂî Āöć÷ëċÜ ñĎšêĉéÿćøđÿóêĉéÖúčŠöĒĂúÖĂăĂúŤìĊęđךćøĆïÖćø ïĈïĆéøĆÖþćĒïïñĎšðśü÷îĂÖĒúąĕöŠÙøïđÖèæŤĔîÖćøüĉîĉÝÞĆ÷ ñĎšêĉé (dependence) êŠĂđîČęĂÜ 3 đéČĂîĀúĆÜÝĈĀîŠć÷ÝćÖÖćøïĈïĆéøĆÖþć ìĆĚÜîĊĚĕöŠøüöñĎšðśü÷ëĎÖÝĆï đÿĊ÷ßĊüĉê ĀøČĂÿŠÜêŠĂ ĀúĆÜ ÝĈĀîŠć÷ÝćÖÖćøïĈïĆéøĆÖþć üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîñúÖćøïĈïéøĆ ĆÖþćñĎšêĉé÷ćđÿóêéÖú ĉ čŠö alcohol ĔîéšćîÖćøđÿøĉöóúĆÜĔĀšöćøĆïÖćø êĉéêćöĒúąĀ÷čéđÿóêŠĂđîČęĂÜ ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšêĉéÿčøćìĊęđךćøĆïÖćøïĈïĆéøĆÖþćĒïïñĎšðśü÷îĂÖ ìĊęĀ÷čéđÿóêŠĂđîČęĂÜ 3 đéČĂî ĀúĆÜÝĈĀîŠć÷ÝćÖÖćøïĈïéøĆ ĆÖþć êĆüĀćø b = ÝĈîüîñĎšêĉéÿčøćìđ×Ċę šćøĆïÖćøïĈïĆéøĆÖþćĒïïñĎšðśü÷îĂÖ ìĊęÝĈĀîŠć÷ÝćÖÖćøïĈïéøĆ ĆÖþć ìĆĚÜĀöéĔîĕêøöćÿÖŠĂîĀîšć øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ F10.0-F10.9 êĆüĀćø F10.0-F10.9 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖ 3 đéČĂî ĀøČĂ ìčÖĕêøöćÿ (êĆüßĊĚüĆéøć÷ĕêøöćÿ) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * åćîךĂöĎúÿëćïĆîïĈïĆéøĆÖþćĒúąôŚŪîôĎñĎšêĉé÷ćđÿóêéĒĀ ĉ ŠÜßćêĉïøöøćßßîîĊĒúąēøÜó÷ćïćú íĆââćøĆÖþõŤ ĎöĉõćÙ üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÿëćïĆîïĈïĆéøĆÖþćĒúąôŚŪîôĎñĎšêé÷ćđÿóê ĉ éĒĀ ĉ ŠÜßćêĉïøöøćßßîîĊĒúąēøÜó÷ćïćúíââć Ć øĆÖþŤõĎöĉõćÙ üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2558 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč êĆüĂ÷ŠćÜÖćøøć÷ÜćîñúÖćøéĈđîĉîÜćîĕêøöćÿìĊę 1 (1 ê.Ù.-31 í.Ù.) ĔßšåćîךĂöĎúñĎšðśü÷ìĊę ÝĈĀîŠć÷ÝćÖÖćøïĈïĆéøĆÖþćìčÖÖøèĊìĆĚÜÙøïđÖèæŤÖĈĀîé ĒúąĕöŠÙøïđÖèæŤÖĈĀîé (÷ÖđüšîëĎÖÝĆï đÿĊ÷ßĊüĉê ĀøČĂ ÿŠÜêŠĂ) ĔîĕêøöćÿÖŠĂîĀîšć (1 Ö.Ù.–30 Ö.÷.) ĒúšüĀ÷čéđÿó êŠĂđîČęĂÜ 3 đéČĂî ĔîĀšüÜ 1 ê.Ù.-31 í.Ù. G DS0201

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 128 ðøąđõì DS03 Tobacco group ĀöüéêĆüßĊĚüĆé Substance use disorder ðøąđõìêĆüßĊĚüĆé Tobacco group øĀĆÿêĆüßĊĚüĆé DS0301 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úą×ĂÜñêĎšĉé÷ćÿĎïēé÷øüö ìĊęĀ÷čéđÿóêŠĂđîČęĂÜ 3 đéČĂî ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Tobacco group: 3 months total remission rate îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé ñĎšêĉé÷ćÿĎï (tobacco) Āöć÷ëċÜ ñĎšêĉéñúĉêõĆèæŤÝćÖĔï÷ćÿĎïìčÖßîĉé đߊî ïčĀøĊę (cigarette) ïčĀøĊęöüîđĂÜ (÷ćđÿšî) àĉÖćøŤïčĀøĊęĕôôŜć ïćøćÖĎŠ Ā÷čéđÿóêŠĂđîČęĂÜ 3 đéČĂî Āöć÷ëċÜ ñĎšêĉé÷ćÿĎï ìĊęđךćøĆïÖćøïĈïĆéøĆÖþćĒïïñĎšðśü÷îĂÖ ìĊęĕöŠÙøïđÖèæŤĔîÖćøüĉîĉÝÞĆ÷ ñĎšêĉé (dependence) êŠĂđîČęĂÜ 3 đéČĂîĀúĆÜÝĈĀîŠć÷ÝćÖÖćø ïĈïĆéøĆÖþć ìĆĚÜîĊĚĕöŠøüöñĎšðśü÷ëĎÖÝĆï đÿĊ÷ßĊüĉê ĀøČĂÿŠÜêŠĂ ĀúĆÜÝĈĀîŠć÷ÝćÖÖćøïĈïĆéøĆÖþć üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîñúÖćøïĈïéøĆ ĆÖþćñĎšêĉé÷ćđÿóêéÖú ĉ čŠö tobacco ĔîéćîÖćøđÿø š ĉöóúĆÜĔĀšöćøĆïÖćø êĉéêćöĒúąĀ÷čéđÿóêŠĂđîČęĂÜ ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšêĉé÷ćÿĎïìĊęđךćøĆïÖćøïĈïĆéøĆÖþćĒïïñĎšðśü÷îĂÖ Ā÷éđÿóê č ŠĂđîČęĂÜ 3 đéČĂî ĀúĆÜÝĈĀîŠć÷ÝćÖÖćøïĈïéøĆ ĆÖþć êĆüĀćø b = ÝĈîüîñĎšêĉé÷ćÿĎïìđ×Ċę šćøĆïÖćøïĈïĆéøĆÖþćĒïïñĎšðśü÷îĂÖ ìĊęÝĈĀîŠć÷ÝćÖÖćø ïĈïĆéøĆÖþćìĆĚÜĀöéĔîĕêøöćÿÖŠĂîĀîšć øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ F17.0-F17.9 êĆüĀćø F17.0-F17.9 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖ 3 đéČĂî ĀøČĂ ìčÖĕêøöćÿ (êĆüßĊĚüĆéøć÷ĕêøöćÿ) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * åćîךĂöĎúÿëćïĆîïĈïĆéøĆÖþćĒúąôŚŪîôĎñĎšêĉé÷ćđÿóêéĒĀ ĉ ŠÜßćêĉïøöøćßßîîĊĒúąēøÜó÷ćïćú íĆââćøĆÖþõŤ ĎöĉõćÙ üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÿëćïĆîïĈïĆéøĆÖþćĒúąôŚŪîôĎñĎšêé÷ćđÿóê ĉ éĒĀ ĉ ŠÜßćêĉïøöøćßßîîĊĒúąēøÜó÷ćïćúíââć Ć øĆÖþŤõĎöĉõćÙ üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2558 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč êĆüĂ÷ŠćÜÖćøøć÷ÜćîñúÖćøéĈđîĉîÜćîĕêøöćÿìĊę 1 (1 ê.Ù.-31 í.Ù.) ĔßšåćîךĂöĎúñĎšðśü÷ìĊę ÝĈĀîŠć÷ÝćÖÖćøïĈïĆéøĆÖþćìčÖÖøèĊìĆĚÜÙøïđÖèæŤÖĈĀîé ĒúąĕöŠÙøïđÖèæŤÖĈĀîé (÷ÖđüšîëĎÖÝĆï đÿĊ÷ßĊüĉê ĀøČĂ ÿŠÜêŠĂ) ĔîĕêøöćÿÖŠĂîĀîšć (1 Ö.Ù.–30 Ö.÷.) ĒúšüĀ÷čéđÿó êŠĂđîČęĂÜ 3 đéČĂî ĔîĀšüÜ 1 ê.Ù.-31 í.Ù. G DS0301

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 129 ðøąđõì DS04 Opioid group ĀöüéêĆüßĊĚüĆé Substance use disorder ðøąđõìêĆüßĊĚüĆé Opioid group øĀĆÿêĆüßĊĚüĆé DS0401 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) ĂĆêøćÙÜĂ÷ĎŠĔîÖćøïĈïéøĆ ĆÖþć 1 ðŘéšü÷đöìćēéîøą÷ą÷ćü ×ĂÜñĎšêéÿćøđÿóê ĉ ĉéĔîÖúöčŠ opioid ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Opioid group: 1 year retention rate of opioid in methadone maintenance program îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšêĉé÷ćđÿóêéĔîÖú ĉ čŠö opioid Āöć÷ëċÜ ñĎšêé÷ćđÿóê ĉ ĉé ĔîÖúčŠö đăēøĂĊî öĂøŤôŘî òŗũîĒúą ĂîčóĆîíŤ×ĂÜòŗũî 2. ÙÜĂ÷ĎŠĔîÖćøïĈïĆéøĆÖþć 1 ðŘĀöć÷ëċÜ ñĎšðśü÷ìĊęêĉé÷ćđÿóêĉéĔîÖúöčŠ Opioid ìĊęöćøĆïÖćø ïĈïĆéøĆÖþćéšü÷đöìćēéîøą÷ą÷ćü êŠĂđîČęĂÜÝîÙøï 1 ðŘēé÷ĕöŠ×ćéÖćøøĆÖþćêŠĂđîČęĂÜđÖĉî 1 đéČĂî ìĆĚÜîĊĚĕöŠøüöñĎšðśü÷ìĊęëĎÖÝĆï đÿĊ÷ßĊüĉê ĀøČĂ ÿŠÜêŠĂĕðøĆïđöìćēéîøą÷ą÷ćüìĊę ÿëćîó÷ćïćúĂČęî üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîñúÖćøïĈïéøĆ ĆÖþćñĎšêĉé÷ćđÿóêéÖú ĉ čŠö Opioid ÿĎêøĔîÖćøÙĈîüè (a/b) x 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷îĂÖ øąïïÿöĆÙøĔÝìĊęđøĉęöïĈïĆéøĆÖþćĔîĒêŠúąĕêøöćÿ×ĂÜðŘÜïðøąöćèìĊę ñŠćîöć ĕéšøĆïÖćøïĈïéøĆ ĆÖþćéšü÷đöìćēéîøą÷ą÷ćü ĒúąÙÜĂ÷ĎŠĔîÖćøøĆÖþćÝîÙøï 1 ðŘ ×ċĚîĕð ĔîĒêŠúąĕêøöćÿ×ĂÜðŘÜïðøąöćèðŦÝÝčïĆî êĆüĀćø b = ÝĈîüîñĎšðśü÷îĂÖ øąïïÿöĆÙøĔÝìĊęđøĉęöÖćøïĈïĆéøĆÖþćĔîĒêúąĕêøöćÿ×ĂÜ Š ðŘÜïðøąöćèìĊęñŠćîöć ĕéøšĆïÖćøïĈïĆéøĆÖþćéšü÷đöìćēéîøą÷ą÷ćüìĆĚÜĀöé øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ F11.0-F11.9 êĆüĀćø F11.0-F11.9 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖ 3 đéČĂî ĀøČĂ ìčÖĕêøöćÿ (êĆüßĊĚüĆéøć÷ĕêøöćÿ) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * åćîךĂöĎúÿëćïĆîïĈïĆéøĆÖþćĒúąôŚŪîôĎñĎšêĉé÷ćđÿóêéĒĀ ĉ ŠÜßćêĉïøöøćßßîîĊĒúą ēøÜó÷ćïćúíââćø Ć ĆÖþŤõĎöõćÙ ĉ üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÿëćïĆîïĈïĆéøĆÖþćĒúąôŚŪîôĎñĎšêé÷ćđÿóê ĉ éĒĀ ĉ ŠÜßćêĉïøöøćßßîîĊĒúąēøÜó÷ćïćúíââć Ć øĆÖþŤõĎöĉõćÙ üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2558 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč êĆüĂ÷ŠćÜÖćøøć÷ÜćîñúÖćøéĈđîĉîÜćîĕêøöćÿìĊę 1 ðŘÜïðøąöćè 2559 ĔßšåćîךĂöĎúñĎšðśü÷ ìĊęĕéšøĆïÖćøïĈïĆéøĆÖþćéšü÷đöìćēéîĔîĀšüÜ 1 ê.Ù.–31 í.Ù. 57 Ēúšü÷ĆÜÙÜĂ÷ĎŠĔîÖćøøĆÖþć êŠĂđîČęĂÜđðŨîøą÷ąđüúć 1 ðŘĔîĀšüÜ 1 ê.Ù.-31 í.Ù. 58 G CS0401

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 130 Āöüé DE: Center of excellence (E) ðøąđõì DE01 Breast cancer ĀöüéêĆüßĊĚüĆé Center of excellence ðøąđõìêĆüßĊĚüĆé Breast cancer øĀĆÿêĆüßĊĚüĆé DE0101 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øą÷ąđüúćÖćøøĂêøüÝõć÷ĀúĆÜÖćøÿŠÜðøċÖþć×ĂÜñĎšðśü÷ìöĊę ĊñúđööēöĒÖøöêĆĚÜĒêŠ BI-RADS 4×ċĚîĕð ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Breast cancer: Consultation time in patient with BIRADS 4 or greater mammography result îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé ÝĈîüîüĆîøĂêøüÝđÞúĊę÷ Āöć÷ëċÜ ÝĈîüîüĆîêĆĚÜĒêŠøĆÜÿĊĒóì÷Ťøć÷ÜćîñúÖćøêøüÝ (ĒööēöĒÖøöđðŨî BI-RADS 4 ×ċĚîĕð) ÝîëċÜüĆîìĊęñĎšðśü÷ĕéšđךćøĆïÖćøêøüÝÖĆïýĆú÷Ēóì÷Ťđêšćîö üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉõćó×ĂÜÖćøÿŠÜêøüÝðøċÖþćĒóì÷ŤđÞóćąìćÜ ÿĎêøĔîÖćøÙĈîüè a/b ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ A= ÝĈîüîüĆî øĂêøüÝÖĆïýú÷Ēóì÷ Ć Ťđêšćîöøüö ×ĂÜñĎšðśü÷ BI-RADS 4 ×ċĚîĕðìĆĚÜĀöé (ĀîŠü÷ = üĆî) êĆüĀćø B= ÝĈîüîñĎšðśü÷ BI-RADS 4 ×ċĚîĕðìĆĚÜĀöé (ĀîŠü÷ = øć÷) øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ - êĆüĀćø - ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖ 1 ðŘ (êĆüßĊĚüĆéøć÷ðŘ) ĀîŠü÷üĆé ÝĈîüîüĆî Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜîšĂ÷ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÙèąĂîčÖøøöÖćøøąïïÙčèõćóĒúąóĆçîćêĆüßĊĚüĆé, đÙøČĂ׊ć÷ēøÜó÷ćïćúÖúöÿëćï čŠ Ćî Ēóì÷ýćÿêøŤĒĀŠÜðøąđìýĕì÷ (UHosNet) üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2560 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé 1 êčúćÙö 2562 đĀêčñú×ĂÜÖćøðøĆïðøčÜ ðøĆïðøčÜÙøĆĚÜìĊę1 (êčúćÙö 2562): ðøĆïðøčÜßČęĂêĆüßĊĚüĆéĔĀšëĎÖêšĂÜĒúąÿĂéÙúšĂÜ Āöć÷đĀêč DE0101

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 131 ĀöüéêĆüßĊĚüĆé Center of excellence ðøąđõìêĆüßĊĚüĆé Breast cancer øĀĆÿêĆüßĊĚüĆé DE0103 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąÖćøêøüÝóïñĎšðśü÷öąđøĘÜđêšćîöøą÷ąĒøÖ Stage 1, 2 ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Breast Cancer: Percent of early diagnosis of stage 1, 2 îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷öąđøĘÜđêšćîö Āöć÷ëċÜ ñĎšðśü÷ìĆĚÜĔîÿëćîąñĎšðśü÷îĂÖĒúąñĎšðśü÷ĔîìĊęöĊPrincipal diagnosis (Pdx) or Secondary diagnosis (sdx) đðŨîēøÙöąđøĘÜđêšćîö ēé÷öĊøĀĆÿēøÙêćö ICD-10 TM, ICD-10, ICD-9 éĆÜìĊęøąïčĕüšîĊĚ 2. öąđøĘÜđêšćîöøą÷ąìĊę 1 Āöć÷ëċÜ öąđøĘÜöĊÖćøúčÖúćöĂĂÖöćîĂÖđîČĚĂđ÷ČęĂåćîøćÖ ĒêŠ÷ĆÜ ĕöŠöĊÖćøĒóøŠÖøąÝć÷ĕðÿĎŠêŠĂöîĚĈđĀúČĂÜìĊęøĆÖĒøšĒúą×îćéÖšĂîöąđøĘÜĕöŠđÖĉî 2 àö. 3. öąđøĘÜđêšćîöøą÷ąìĊę 2 Āöć÷ëċÜ ÖšĂîöąđøĘÜ×îćéđÖĉî 2 àö. ĒêŠĕöŠđÖĉî 5 àö. ìĊę÷ĆÜĕöŠöĊ ÖćøĒóøŠÖøąÝć÷ĕðÿĎŠêŠĂöîĚĈđĀúČĂÜìĊęøĆÖĒøšĀøČĂöąđøĘÜ×îćéđúĘÖĕöŠđÖĉî 2 àö. ĒêŠöĊÖćø ĒóøŠÖøąÝć÷ĕðÿĎŠêŠĂöîĚĈđĀúČĂÜìĊęøĆÖĒøšĒúšü üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé đóČęĂðøąđöĉîøąéĆïÙüćöøčîĒøÜ×ĂÜēøÙ (stage) ×ĂÜñĎšðśü÷öąđøĘÜđêšćîöìĊęđךćøĆïÖćøêøüÝ øĆÖþćĔîēøÜó÷ćïćú ÿĎêøĔîÖćøÙĈîüè (a/b) × 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷øć÷ĔĀöŠĕéšøĆïÖćøüĉîĉÝÞĆ÷Ĕîÿëćîó÷ćïćúîĆĚîüŠćđðîöąđø Ũ ĘÜđêšćîöøą÷ąìĊę 1 ĀøČĂ øą÷ąìĊę 2 ĔîøĂïðŘ êĆüĀćø B = ÝĈîüîñĎšðśü÷öąđøĘÜđêšćîöøć÷ĔĀöŠìĊęĕéøšĆïüĉîĉÝÞĆ÷ĔîÿëćïĆîîĆĚîìĆĚÜĀöéĔîøĂïðŘ øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = C50 ĒúąĂ÷ĎŠĔîøą÷ąìĊę 1 ĀøČĂøą÷ąìĊę 2 êĆüĀćø Pdx = C50 ĒúąĕéøšĆïÖćøüĉîÝÞĉ Ć÷üŠćđðŨîöąđøĘÜđêšćîöøć÷ĔĀöŠ ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖ 1 ðŘ (êĆüßĊĚüĆéøć÷ðŘ) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóé Ċ ìĊęöć/ Reference ÙèąĂîčÖøøöÖćøøąïïÙčèõćóĒúąóĆçîćêĆüßĊĚüĆé, đÙøČĂ׊ć÷ēøÜó÷ćïćúÖúöÿëćï čŠ Ćî Ēóì÷ýćÿêøŤĒĀŠÜðøąđìýĕì÷ (UHosNet) üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2560 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč G DE0103

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 132 ðøąđõì DE05 Stem cell transplantation ĀöüéêĆüßĊĚüĆé Center of excellence ðøąđõìêĆüßĊĚüĆé Stem cell transplantation øĀĆÿêĆüßĊĚüĆé DE0501 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) ĂĆêøćÖćøðúĎÖëŠć÷êĉé (engraftment) ×ĂÜñĎšðśü÷ Stem cell transplantation õć÷Ĕî 45 üĆî ĀúĆÜÖćøðúĎÖëŠć÷ĕ×ÖøąéĎÖ ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Stem cell transplantation: Engraftment rate within 45 days îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé ÖćøøĆÖþćéšü÷ÖćøðúĎÖëŠć÷ĕ×ÖøąéĎÖĀøČĂÖćøðúĎÖëŠć÷đàúúŤêšîÖĈđîéđö ĉ ĘéđúČĂéìĊęðøąÿï ñúÿĈđøĘÝìĊęöĊÖćøðúĎÖëŠć÷êĉé (engraftment) õć÷Ĕî 45 üĆî üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñúĔîÖćøéĎĒúñðĎš śü÷ðúĎÖëŠć÷ĕ×ÖøąéĎÖ ÿĎêøĔîÖćøÙĈîüè (a/b) × 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷ìĊęđךćøĆïÖćøøĆÖþćéšü÷ÖćøðúĎÖëŠć÷ĕ×ÖøąéĎÖìĊęöñú×ĂÜÖćøðú Ċ ĎÖëŠć÷êéĉ (engraftment) õć÷Ĕî 45 üĆî êĆüĀćø b = ÝĈîüîñĎšðśü÷ìĊęđךćøïÖćøø Ć ĆÖþćéšü÷ÖćøðúĎÖëŠć÷ĕ×ÖøąéĎÖìĆĚÜĀöé øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = (ICD-10) D61, C91-C95 Ēúą (ICD-9) ×ĂÜÖćøðúĎÖëŠć÷ĕ×ÖøąéĎÖ øĀĆÿĀêëÖćø Ć 410 Ēúą ñĎšðśü÷öĊengraftment êĆüĀćø Pdx = ICD-10 D61,C91- C95 Ēúą ICD-9 ×ĂÜÖćøðúĎÖëŠć÷ĕ×ÖøąéĎÖ øĀĆÿĀêëÖćø Ć 410 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖ 1 ðŘ (êĆüßĊĚüĆéøć÷ðŘ) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * 95% : Olsson R et al. Graft failure in the modern era of allogeneic hematopoietic sci. Bone Marrow Transplantation/2013 üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÙèąĂîčÖøøöÖćøøąïïÙčèõćóĒúąóĆçîćêĆüßĊĚüĆé, đÙøČĂ׊ć÷ēøÜó÷ćïćúÖúöÿëćï čŠ Ćî Ēóì÷ýćÿêøŤĒĀŠÜðøąđìýĕì÷ (UHosNet) üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2560 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč G DE0501

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 133 ðøąđõì DE08 Thalassemia ĀöüéêĆüßĊĚüĆé Center of excellence ðøąđõìêĆüßĊĚüĆé Thalassemia øĀĆÿêĆüßĊĚüĆé DE0801 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úą×ĂÜñĎšðśü÷ transfusion dependent thalassemia (TDT) ìĊęĂć÷čöćÖÖüŠć 2 ðŘ ĒúąëċÜ 15 ðŘöĊõćüąíćêčđĀúĘÖđÖîĉ (Serum ferritin > 1000 ug/L) ìĊęĕéšøĆï÷ć×ĆïíćêčđĀúĘÖ ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) TDT in Pediatrics Patient: Percent of received iron chelator in patient with iron overload (serum ferrous > 1000 ug/L) îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ñĎšðśü÷ TDT ìĊęĂć÷čöćÖÖüŠć 2 ðŘëċÜ 15 ðŘìĊęöĊõćüąíćêčđĀúĘÖđÖĉî Āöć÷ëċÜ ñĎšĕéšøĆïÖćø êøüÝđßĘÙøąéĆï Serum ferritin Ēúą öĊÙŠć Serum ferritin > 1000 ug/L (Hemochromatosis) 2. ñĎšðśü÷ìĊęöĊÙŠć Serum ferritin > 1000 ug/L ĒúąĕéšøĆï÷ć×ĆïíćêčđĀúĘÖ ĀøČĂ Iron Chelator đߊî Deferasirox, Deferoxamine ĀøČĂ Deferiprone ßîĉéĔéßîĉéĀîċęÜ ĀøČĂĔĀš øŠüöÖĆî üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉõćóĔîÖćøéĎĒúñĎšðśü÷ TDT ĒúąÖćøđòŜćøąüĆÜĕöŠĔĀšöĊõćüąíćêčđĀúĘÖđÖĉî ÿĎêøĔîÖćøÙĈîüè (a/b) × 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷ TDT ìĊęĂć÷čöćÖÖüŠć 2 ðŘĒúąëċÜ 15 ðŘöĊõćüąíćêčđĀúĘÖđÖĉîĕéšøĆï÷ć×Ćï íćêčđĀúĘÖ êĆüĀćø b = ÝĈîüîñĎšðśü÷ TDT ìĊęĂć÷čöćÖÖüŠć 2 ðŘĒúąëċÜ 15 ðŘöĊõćüąíćêčđĀúĘÖđÖĉîìĆĚÜĀöé ĔîߊüÜøą÷ąđüúćđéĊ÷üÖĆî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = øĀĆÿēøÙ ICD-10 D561 ĀøČĂ D560 øŠüöÖĆï øĀĆÿ E831 Ēúą ĕéøšĆï÷ć Iron chelator (øĀÿĆ TMTID (TPU) Deferasirox (Exjade) 250 mg øĀĆÿ 324011 Desferoxamine (Desferal) 500 mg øĀĆÿ 667111 Deferiprone (GPO-Lone) 500 mg øĀĆÿ 339467) êĆüĀćø Pdx = øĀĆÿēøÙ ICD-10 D561 ĀøČĂ D560 øŠüöÖĆï øĀĆÿ E831 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖđéČĂî ĀøČĂ đéČĂîúąÙøĆĚÜ (êĆüßüĊĚĆéøć÷đéČĂî) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÙèąĂîčÖøøöÖćøøąïïÙčèõćóĒúąóĆçîćêĆüßĊĚüĆé, đÙøČĂ׊ć÷ēøÜó÷ćïćúÖúöÿëćï čŠ Ćî Ēóì÷ýćÿêøŤĒĀŠÜðøąđìýĕì÷ (UHosNet) üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2560 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé đĀêčñú×ĂÜÖćøðøĆïðøčÜ Āöć÷đĀêč G DE0801

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 134 ðøąđõì DE12 Cleft lip –Cleft palate and craniofacial disease ĀöüéêĆüßĊĚüĆé Center of excellence ðøąđõìêĆüßĊĚüĆé Cleft lip, Cleft palate øĀĆÿêĆüßĊĚüĆé DE1201 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąñĎšðśü÷ìĊęđךćøĆïÖćøñŠćêéàĆ ŠĂöĒàöðćÖĒĀüŠÜêćöđÖèæŤßŠüÜĂć÷čĕöŠđÖĉî 6 đéČĂî ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Cleft lip: Percent of patients who had cleft lip repair with under 6 months of age îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé ñĎšðśü÷ðćÖĒĀüŠÜđóéćîēĀüŠìĆĚÜßîĉéÿöïĎøèŤĒúąßîĉéĕöŠÿöïĎøèŤ×šćÜđéĊ÷üĒúąÿĂÜךćÜ (unilateral/bilateral complete/incomplete Cleft lip-Cleft palate) ĒúąìĊęöĊõćüą ðćÖĒĀüŠÜĂ÷ŠćÜđéĊ÷ü (cleft lip) ìĊęÙúĂéĔîđ×êìĊęēøÜó÷ćïćúîĆĚîøĆïñĉéßĂï øüöëċÜñĎšðśü÷ìĊę ĕéšøĆïÖćøÿŠÜêŠĂöć ÙøĂïÙúčöëċÜñĎšðśü÷ìĊęĕéšøĆïÖćøÝĆéÿĆîđĀÜČĂÖÖŠĂîñŠćêĆé đóČęĂđךćøĆïÖćø ñŠćêĆéðćÖĒĀüŠÜĔîߊüÜĂć÷čĕöŠđÖĉî 6 đéČĂî ìĊęĔĀšøĀĆÿēøÙêćö ICD-10 ÖúčŠö Q35, Q36, Q37 üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé đóČęĂüĆéðøąÿĉìíĉõćó×ĂÜÖćøđךćëÜïø ċ ĉÖćøĒúąÖćøÿŠÜêŠĂñĎšðśü÷ĔĀđך šćøĆïÖćøñŠćêĆéðćÖĒĀüŠÜ ĔîߊüÜĂć÷čĕöŠđÖĉî 6 đéČĂî ÿĎêøĔîÖćøÙĈîüè (a/b)x100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷ Cleft lip ìĊęđךćøĆïÖćøñŠćêĆéߊüÜĂć÷čĕöŠđÖĉî 6 đéČĂî êĆüĀćø b = ÝĈîüîñĎšðśü÷ Cleft lip ìĊęđךćøĆïÖćøñŠćêĆéìĆĚÜĀöéĔîߊüÜđéĊ÷üÖîĆ øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = ICD-10 Q35, Q36, Q37 ìĊęöĊĂć÷čĕöđÖŠ ĉî 6 đéČĂî Ēúą ICD-9 ×ĂÜÖćøñŠćêĆé Cleft lip øĀĆÿĀêëÖćø Ć 27.54, 27.59 êĆüĀćø Pdx = ICD-10 Q35, Q36, Q37 ìĆĚÜĀöé Ēúą ICD-9 ×ĂÜÖćøñŠćêéĆ Cleft lip øĀÿĆ ĀĆêëÖćø 27.54, 27.59 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖ 3 đéČĂî (êĆüßĊĚüĆéøć÷ĕêøöćÿ) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÙèąĂîčÖøøöÖćøøąïïÙčèõćóĒúąóĆçîćêĆüßĊĚüĆé, đÙøČĂ׊ć÷ēøÜó÷ćïćúÖúöÿëćï čŠ Ćî Ēóì÷ýćÿêøŤĒĀŠÜðøąđìýĕì÷ (UHosNet) üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2560 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé 1 êčúćÙö 2562 đĀêčñú×ĂÜÖćøðøĆïðøčÜ ðøĆïðøčÜîĉ÷ćöĒúąøüïøüöÖćøđÖïêĘ ĆüßĊĚüĆéĔĀšëĎÖêšĂÜĒúąÿĂéÙúšĂÜ Āöć÷đĀêč ĂĆêøćÖćøñŠćêéðćÖĒĀü Ć ŠÜêćöߊüÜĂć÷čĕéšøšĂ÷úą 100 ĀćÖñúúĆóíŤêĈÖü ę ŠćÙŠćđðŜćĀöć÷ëċÜ øšĂ÷úą 10 ÙüøöĊÖćøìïìüîÖćøéĎĒú×ĂÜìĊö G DE1201

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 135 ĀöüéêĆüßĊĚüĆé Center of excellence ðøąđõìêĆüßĊĚüĆé Cleft lip, Cleft palate øĀĆÿêĆüßĊĚüĆé DE1202 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) øšĂ÷úąñĎšðśü÷ìĊęđךćøĆïÖćøñŠćêéàĆ ŠĂöĒàöđóéćîēĀüŠêćöߊüÜĂć÷čĕöđÖŠ ĉî 18 đéČĂî ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Cleft palate: Percent of patients who had cleft Palate repair with under 18 months of age îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé ñĎšðśü÷ðćÖĒĀüŠÜđóéćîēĀüŠìĆĚÜßîĉéÿöïĎøèŤĒúąßîĉéĕöŠÿöïĎøèŤ×šćÜđéĊ÷üĒúąÿĂÜךćÜ (unilateral/bilateral complete/incomplete Cleft lip-Cleft palate) ĒúąìĊęöĊõćüą ðćÖĒĀüŠÜĂ÷ŠćÜđéĊ÷ü (cleft lip) ìĊęÙúĂéĔîđ×êìĊęēøÜó÷ćïćúîĆĚîøĆïñĉéßĂï øüöëċÜ ñĎšðśü÷ìĊęĕéšøĆïÖćøÿŠÜêŠĂöć ÙøĂïÙúčöëċÜñĎšðśü÷ìĊęĕéšøĆïÖćøÝĆéÿĆîđĀÜČĂÖÖŠĂîñŠćêĆéđóČęĂ đךćøĆïÖćøñŠćêĆéðćÖĒĀüŠÜĔîߊüÜĂć÷čĕöŠđÖĉî 18 đéČĂî ìĊęĔĀšøĀĆÿēøÙêćö ICD-10 ÖúčŠö Q35, Q36, Q37 üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé đóČęĂüĆéðøąÿĉìíĉõćó×ĂÜÖćøđךćëċÜïøĉÖćøĒúąÖćøÿŠÜêŠĂñĎšðśü÷ĔĀšđךćøĆïÖćøñŠćêĆé đóéćîēĀüŠĔîߊüÜĂć÷ĕöč ŠđÖĉî 18 đéČĂî ÿĎêøĔîÖćøÙĈîüè (a/b)x100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîñĎšðśü÷ Cleft palate ìĊęđךćøĆïÖćøñŠćêĆéđóéćîēĀüŠõć÷ĔîߊüÜĂć÷čĕöŠđÖĉî 18 đéČĂî êĆüĀćø b = ÝĈîüîñðĎš śü÷ Cleft palate ìĊęđךćøĆïÖćøñŠćêĆéìÜĀöéĔîß ĆĚ üÜđé Š Ċ÷üÖĆî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ Pdx = ICD-10 Q35, Q36, Q37 ìĊęöĊĂć÷čĕöđÖŠ ĉî 18 đéČĂî Ēúą ICD-9 ×ĂÜÖćøñŠćêĆé Cleft palate øĀĆÿĀĆêëÖćø 2762, 2763 êĆüĀćø Pdx = ICD-10 Q35, Q36, Q37 ìĆĚÜĀöé Ēúą ICD-9 ×ĂÜÖćøñŠćêĆé Cleft palate øĀĆÿ ĀĆêëÖćø 2762, 2763 ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖ 3 đéČĂî (êĆüßĊĚüĆéøć÷ĕêøöćÿ) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÙèąĂîčÖøøöÖćøøąïïÙčèõćóĒúąóĆçîćêĆüßĊĚüĆé, đÙøČĂ׊ć÷ēøÜó÷ćïćúÖúöÿëćï čŠ Ćî Ēóì÷ýćÿêøŤĒĀŠÜðøąđìýĕì÷ (UHosNet) üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2560 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé 1 êčúćÙö 2562 đĀêčñú×ĂÜÖćøðøĆïðøčÜ ðøĆïðøčÜîĉ÷ćöĒúąøüïøüöÖćøđÖïêĘ ĆüßĊĚüĆéĔĀšëĎÖêšĂÜĒúąÿĂéÙúšĂÜ Āöć÷đĀêč đóČęĂÖĈĀîéđÖèæŤÖćøĒðúñúĔĀšêøÜÖĆïÙüćöđðŨîÝøĉÜöćÖìĊęÿčéđߊî ĕöŠîĈÖúčŠöēøÙøŠüö ÖúčŠöìĊęöćøĆïÖćøøĆÖþćßšćÖüŠć 18 đéČĂîöćÙĈîüè đÿîĂĔĀšîĆïÖúčŠöĂćÖćøēøÙøŠüöìčÖ ēøÙ đóČęĂĒÿéÜÙüćöđðŨî excellence ×ĂÜēøÜó÷ćïćú G DE1202

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 136 ðøąđõì DE13 Infertility ĀöüéêĆüßĊĚüĆé Center of excellence ðøąđõìêĆüßĊĚüĆé Infertility øĀĆÿêĆüßĊĚüĆé DE1301 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) ĂĆêøćÖćøêĆĚÜÙøøõŤêŠĂøĂïÖćøĔÿêŠ üĂĆ ŠĂî×ĂÜñĎšøĆïïøĉÖćøìĈđéĘÖĀúĂéĒÖšüĒúą÷ć÷ê š ĆüĂŠĂî øĂïÿé (ÖúöĂć÷ čŠ čîšĂ÷ÖüŠć 34 ðŘ) ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Infertility: Clinical pregnancy rate per embryo transfer following IVF/ICSI and fresh embryo transfer (age < 34 years) îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ÖćøìĈđéĘÖĀúĂéĒÖšü Āöć÷ëċÜ ÖćøĔßšđìÙēîēú÷Ċߊü÷ÖćøđÝøĉâóĆîíčŤéšü÷ÖćøðäĉÿîíĉîĂÖ øŠćÜÖć÷ ĂĆîĕéšĒÖŠÖćøñÿöîĂÖøŠćÜÖć÷ĔîÝćîđóćąđú÷ÜĊĚ (standard in vitro fertilisation) ĒúąÖćøÞĊéêĆüĂÿčÝĉđךćđàúúŤĕ׊ēé÷êøÜ (ICSI- intracytoplasmic sperm injection) ēé÷ ìĈÖćø÷šć÷êĆüĂŠĂîøĂïÿéêćöĀúĆÜÖćøÖøąêčšîĒúąđÖĘïĕ׊ đךćĔîēóøÜöéúĎÖ×ĂÜÿêøĊ ñĎšøĆïïøĉÖćø; 2. Clinical pregnancy Āöć÷ëċÜ ÖćøêøüÝéšü÷đÙøČęĂÜÙüćöëĊęÿĎÜ ÷Čî÷ĆîÖćøêĆĚÜÙøøõŤ×ĂÜ êĆüĂŠĂîöĊßĊó (öĊÖćøđêšî×ĂÜĀĆüĔÝ) ĔîēóøÜöéúĎÖìĊęĂć÷čÙøøõŤ 6-8 ÿĆðéćĀŤĀøČĂ 3-5 ÿĆðéćĀŤ ĀúĆÜÖćøĔÿŠêĆüĂŠĂî üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñúÖćøøĆÖþćéšü÷đìÙēîēú÷Ċߊü÷ÖćøđÝøâóĉ ĆîíčŤ ÿĎêøĔîÖćøÙĈîüè (a/b) × 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîÿêøñĊĎšøĆïïøĉÖćøìĕéĊę šøïÖćø÷ Ć Čî÷ĆîÖćøêĆĚÜÙøøõŤ(ÖúöĂć÷ čŠ čîšĂ÷ÖüŠć 34 ðŘ) ìöĊę Ċ Öćøđêšî×ĂÜĀĆüĔÝìćøÖ ÝćÖÖćøêøüÝéšü÷đÙøČęĂÜÙüćöëĊęÿĎÜ ÝćÖÖćøĔÿŠêĆüĂŠĂîøĂïÿé ĔîߊüÜøą÷ąđüúćĀîċęÜðŘ êĆüĀćø b = ÝĈîüîÙøĆĚÜ×ĂÜÖćøĔÿŠêĆüĂŠĂî×ĂÜñĎšøĆïïøĉÖćøìĈđéĘÖĀúĂéĒÖšüĒúą÷šć÷êĆüĂŠĂî øĂïÿéìĆĚÜĀöé (ÖúčŠöĂć÷čîĂ÷Öü š ćŠ 34 ðŘ) ĔîߊüÜđüúćđéĊ÷üÖĆî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ êĆüĀćø ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖ 1 ðŘ (êĆüßĊĚüĆéøć÷ðŘ) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * øšĂ÷úą 30, ÿöćÙöîĆÖüĉì÷ćýćÿêøŤđóćąđú÷Üê ĊĚ ĆüĂŠĂîĒĀŠÜðøąđìýĕì÷ ÿî.óì. üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÙèąĂîčÖøøöÖćøøąïïÙčèõćóĒúąóĆçîćêĆüßĊĚüĆé, đÙøČĂ׊ć÷ēøÜó÷ćïćúÖúöÿëćï čŠ Ćî Ēóì÷ýćÿêøŤĒĀŠÜðøąđìýĕì÷ (UHosNet) üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2560 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé Āöć÷đĀêč ךĂöĎúđÖĘïøüïøüöđóČęĂøć÷ÜćîÖøöÿîĆïÿîčîïøĉÖćøÿč×õćó êćö óøï.ÙčšöÙøĂÜđéĘÖìĊęđÖĉé ÝćÖđìÙēîēú÷Ċߊü÷ÖćøđÝøâóĉ ĆîíčŤóý.2558 ĒúąÖãĀöć÷ìĊęđÖĊę÷üךĂÜ G DE1301

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 137 ĀöüéêĆüßĊĚüĆé Center of excellence ðøąđõìêĆüßĊĚüĆé Infertility øĀĆÿêĆüßĊĚüĆé DE1302 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) ĂĆêøćÖćøêĆĚÜÙøøõŤêŠĂøĂïÖćøĔÿêŠ üĂĆ ŠĂî×ĂÜñĎšøĆïïøĉÖćøìĈđéĘÖĀúĂéĒÖšüĒúą÷ć÷ê š ĆüĂŠĂî øĂïÿé (ÖúöĂć÷ čŠ č 34 - 39 ðŘ) ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Infertility: Clinical pregnancy rate per embryo transfer following IVF/ICSI and fresh embryo transfer (age 34 - 39 Years) îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ÖćøìĈđéĘÖĀúĂéĒÖšü Āöć÷ëċÜ ÖćøĔßšđìÙēîēú÷Ċߊü÷ÖćøđÝøĉâóĆîíčŤéšü÷ÖćøðäĉÿîíĉîĂÖ øŠćÜÖć÷ ĂĆîĕéšĒÖŠÖćøñÿöîĂÖøŠćÜÖć÷ĔîÝćîđóćąđú÷ÜĊĚ (standard in vitro fertilisation) ĒúąÖćøÞĊéêĆüĂÿčÝĉđךćđàúúŤĕ׊ēé÷êøÜ (ICSI- intracytoplasmic sperm injection) ēé÷ ìĈÖćø÷šć÷êĆüĂŠĂîøĂïÿéêćöĀúĆÜÖćøÖøąêčšîĒúąđÖĘïĕ׊ đךćĔîēóøÜöéúĎÖ×ĂÜÿêøĊ ñĎšøĆïïøĉÖćø 2. Clinical pregnancy Āöć÷ëċÜ ÖćøêøüÝéšü÷đÙøČęĂÜÙüćöëĊęÿĎÜ ÷Čî÷ĆîÖćøêĆĚÜÙøøõŤ×ĂÜêĆü ĂŠĂîöĊßĊó (öĊÖćøđêšî×ĂÜĀĆüĔÝ) ĔîēóøÜöéúĎÖìĊęĂć÷čÙøøõŤ 6-8 ÿĆðéćĀŤĀøČĂ 3-5 ÿĆðéćĀŤ ĀúĆÜÖćøĔÿŠêĆüĂŠĂî üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíñúÖćøø ĉ ĆÖþćéšü÷đìÙēîēú÷Ċߊü÷ÖćøđÝøâóĉ ĆîíčŤ ÿĎêøĔîÖćøÙĈîüè (a/b) × 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîÿêøñĊĎšøĆïïøĉÖćøìĕéĊę šøïÖćø÷ Ć Čî÷ĆîÖćøêĆĚÜÙøøõŤ(ÖúöĂć÷ čŠ č 34 - 39 ð)Ř ìĊęöĊÖćø đêšî×ĂÜĀĆüĔÝìćøÖ ÝćÖÖćøêøüÝéšü÷đÙøČęĂÜÙüćöëĊęÿĎÜ ÝćÖÖćøĔÿŠêüĂĆ ŠĂîøĂïÿé ĔîߊüÜ øą÷ąđüúćĀîċęÜðŘ êĆüĀćø b = ÝĈîüîÙøĆĚÜ×ĂÜÖćøĔÿŠêĆüĂŠĂî×ĂÜñĎšøĆïïøĉÖćøìĈđéĘÖĀúĂéĒÖšüĒúą÷šć÷êĆüĂŠĂîøĂïÿé ìĆĚÜĀöé (ÖúčŠöĂć÷č 34-39 ð)ŘĔîߊüÜđüúćđéĊ÷üÖĆî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ êĆüĀćø ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖ 1 ðŘ (êĆüßĊĚüĆéøć÷ðŘ) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÙèąĂîčÖøøöÖćøøąïïÙčèõćóĒúąóĆçîćêĆüßĊĚüĆé, đÙøČĂ׊ć÷ēøÜó÷ćïćúÖúöÿëćï čŠ Ćî Ēóì÷ýćÿêøŤĒĀŠÜðøąđìýĕì÷ (UHosNet) üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2560 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé Āöć÷đĀêč ךĂöĎúđÖĘïøüïøüöđóČęĂøć÷ÜćîÖøöÿîĆïÿîčîïøĉÖćøÿč×õćó êćö óøï.ÙčšöÙøĂÜđéĘÖìĊęđÖĉé ÝćÖđìÙēîēú÷Ċߊü÷ÖćøđÝøâóĉ ĆîíčŤóý.2558 ĒúąÖãĀöć÷ìĊęđÖĊę÷üךĂÜ G DE1302

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 138 ĀöüéêĆüßĊĚüĆé Center of excellence ðøąđõìêĆüßĊĚüĆé Infertility øĀĆÿêĆüßĊĚüĆé DE1303 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) ĂĆêøćÖćøêĆĚÜÙøøõŤêŠĂøĂïÖćøĔÿêŠ üĂĆ ŠĂî×ĂÜñĎšøĆïïøĉÖćøìĈđéĘÖĀúĂéĒÖšüĒúą÷ć÷ê š ĆüĂŠĂî øĂïÿé (ÖúöĂć÷ čŠ č 40 ðŘ×ċĚîĕð) ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Infertility: Clinical pregnancy rate per embryo transfer following IVF/ICSI and fresh embryo transfer (age > 40 years) îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ÖćøìĈđéĘÖĀúĂéĒÖšü Āöć÷ëċÜ ÖćøĔßšđìÙēîēú÷Ċߊü÷ÖćøđÝøĉâóĆîíčŤéšü÷ÖćøðäĉÿîíĉîĂÖ øŠćÜÖć÷ ĂĆîĕéšĒÖŠÖćøñÿöîĂÖøŠćÜÖć÷ĔîÝćîđóćąđú÷ÜĊĚ (standard in vitro fertilisation) ĒúąÖćøÞĊéêĆüĂÿčÝĉđךćđàúúŤĕ׊ēé÷êøÜ (ICSI- intracytoplasmic sperm injection) ēé÷ ìĈÖćø÷šć÷êĆüĂŠĂîøĂïÿéêćöĀúĆÜÖćøÖøąêčšîĒúąđÖĘïĕ׊ đךćĔîēóøÜöéúĎÖ×ĂÜÿêøĊ ñĎšøĆïïøĉÖćø 2. Clinical pregnancy Āöć÷ëċÜ ÖćøêøüÝéšü÷đÙøČęĂÜÙüćöëĊęÿĎÜ ÷Čî÷ĆîÖćøêĆĚÜÙøøõŤ×ĂÜêĆü ĂŠĂîöĊßĊó (öĊÖćøđêšî×ĂÜĀĆüĔÝ) ĔîēóøÜöéúĎÖìĊęĂć÷čÙøøõŤ 6-8 ÿĆðéćĀŤĀøČĂ 3-5 ÿĆðéćĀŤ ĀúĆÜÖćøĔÿŠêĆüĂŠĂî üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíñúÖćøø ĉ ĆÖþćéšü÷đìÙēîēú÷Ċߊü÷ÖćøđÝøâóĉ ĆîíčŤ ÿĎêøĔîÖćøÙĈîüè (a/b) × 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîÿêøñĊĎšøĆïïøĉÖćøìĕéĊę šøïÖćø÷ Ć Čî÷ĆîÖćøêĆĚÜÙøøõŤ(ÖúöĂć÷ čŠ č40 ðŘ×ċĚîĕð) ìĊęöĊÖćø đêšî×ĂÜĀĆüĔÝìćøÖ ÝćÖÖćøêøüÝéšü÷đÙøČęĂÜÙüćöëĊęÿĎÜ ÝćÖÖćøĔÿŠêüĂĆ ŠĂîøĂïÿé ĔîߊüÜ øą÷ąđüúćĀîċęÜðŘ êĆüĀćø b = ÝĈîüîÙøĆĚÜ×ĂÜÖćøĔÿŠêĆüĂŠĂî×ĂÜñĎšøĆïïøĉÖćøìĈđéĘÖĀúĂéĒÖšüĒúą÷šć÷êĆüĂŠĂîøĂïÿé ìĆĚÜĀöé (ÖúčŠöĂć÷č 40 ðŘ×ċĚîĕð) ĔîߊüÜđüúćđéĊ÷üÖĆî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ êĆüĀćø ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖ 1 ðŘ (êĆüßĊĚüĆéøć÷ðŘ) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÙèąĂîčÖøøöÖćøøąïïÙčèõćóĒúąóĆçîćêĆüßĊĚüĆé, đÙøČĂ׊ć÷ēøÜó÷ćïćúÖúöÿëćï čŠ Ćî Ēóì÷ýćÿêøŤĒĀŠÜðøąđìýĕì÷ (UHosNet) üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2560 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé Āöć÷đĀêč ךĂöĎúđÖĘïøüïøüöđóČęĂøć÷ÜćîÖøöÿîĆïÿîčîïøĉÖćøÿč×õćó êćö óøï.ÙčšöÙøĂÜđéĘÖìĊęđÖĉé ÝćÖđìÙēîēú÷Ċߊü÷ÖćøđÝøâóĉ ĆîíčŤóý.2558 ĒúąÖãĀöć÷ìĊęđÖĊę÷üךĂÜ G DE1303

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 139 ĀöüéêĆüßĊĚüĆé Center of excellence ðøąđõìêĆüßĊĚüĆé Infertility øĀĆÿêĆüßĊĚüĆé DE1304 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) ĂĆêøćÖćøêĆĚÜÙøøõŤêŠĂøĂïÖćøĔÿêŠ üĂĆ ŠĂî×ĂÜñĎšøĆïïøĉÖćøìĈđéĘÖĀúĂéĒÖšüĒúą÷ć÷ê š ĆüĂŠĂî øĂïĒߊĒ×ĘÜ (ÖúčŠöĂć÷čîšĂ÷ÖüŠć 34 ðŘ) ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Infertility: Clinical pregnancy rate per embryo transfer following IVF/ICSI and frozen embryo transfer (age < 34 years) îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ÖćøìĈđéĘÖĀúĂéĒÖšü Āöć÷ëċÜ ÖćøĔßšđìÙēîēú÷Ċߊü÷ÖćøđÝøĉâóĆîíčŤéšü÷ÖćøðäĉÿîíĉîĂÖ øŠćÜÖć÷ ĂĆîĕéšĒÖŠÖćøñÿöîĂÖøŠćÜÖć÷ĔîÝćîđóćąđú÷ÜĊĚ (standard in vitro fertilisation) ĒúąÖćøÞĊéêĆüĂÿčÝĉđךćđàúúŤĕ׊ēé÷êøÜ (ICSI-intracytoplasmic sperm injection) ēé÷ìĈ Öćø÷šć÷êĆüĂŠĂîìĊęñŠćîÖćøĒߊĒ×ĘÜ úąúć÷ Ēúą/ĀøČĂđóćąđúĊĚ÷ÜêŠĂĀúĆÜúąúć÷êĆüĂŠĂî đךćĔîēóøÜöéúĎÖ×ĂÜÿêøĊñĎšøĆïïøĉÖćø 2. Clinical pregnancy Āöć÷ëċÜ ÖćøêøüÝéšü÷đÙøČęĂÜÙüćöëĊęÿĎÜ ÷Čî÷ĆîÖćøêĆĚÜÙøøõŤ×ĂÜêĆü ĂŠĂîöĊßĊó (öĊÖćøđêšî×ĂÜĀĆüĔÝ) ĔîēóøÜöéúĎÖìĊęĂć÷čÙøøõŤ 6-8 ÿĆðéćĀŤĀøČĂ 3-5 ÿĆðéćĀŤ ĀúĆÜÖćøĔÿŠêĆüĂŠĂî üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñúÖćøøĆÖþćéšü÷đìÙēîēú÷Ċߊü÷ÖćøđÝøâóĉ ĆîíčŤ ÿĎêøĔîÖćøÙĈîüè (a/b) × 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîÿêøñĊĎšøĆïïøĉÖćøìĕéĊę šøïÖćø÷ Ć Čî÷ĆîÖćøêĆĚÜÙøøõŤ(ÖúöĂć÷ čŠ čîšĂ÷ÖüŠć 34 ðŘ) ìĊęöĊ Öćøđêšî×ĂÜĀĆüĔÝìćøÖ ÝćÖÖćøêøüÝéšü÷đÙøČęĂÜÙüćöëĊęÿĎÜ ÝćÖÖćøĔÿŠêĆüĂŠĂîøĂïĒߊĒ×ĘÜ ĔîߊüÜøą÷ąđüúćĀîċęÜðŘ êĆüĀćø b = ÝĈîüîÙøĆĚÜ×ĂÜÖćøĔÿŠêĆüĂŠĂî×ĂÜñĎšøĆïïøĉÖćøìĈđéĘÖĀúĂéĒÖšüĒúą÷šć÷êĆüĂŠĂî øĂïĒߊĒ×ĘÜìĆĚÜĀöé (ÖúöĂć÷ čŠ čîšĂ÷ÖüŠć 34 ðŘ) ĔîߊüÜđüúćđéĊ÷üÖĆî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ êĆüĀćø ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖ 1 ðŘ (êĆüßĊĚüĆéøć÷ðŘ) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * øšĂ÷úą 30, ÿöćÙöîĆÖüĉì÷ćýćÿêøŤđóćąđú÷Üê ĊĚ ĆüĂŠĂîĒĀŠÜðøąđìýĕì÷ ÿî.óì. üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÙèąĂîčÖøøöÖćøøąïïÙčèõćóĒúąóĆçîćêĆüßĊĚüĆé, đÙøČĂ׊ć÷ēøÜó÷ćïćúÖúöÿëćï čŠ Ćî Ēóì÷ýćÿêøŤĒĀŠÜðøąđìýĕì÷ (UHosNet) üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2560 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé Āöć÷đĀêč G DE1304

Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 BY NC SA T H I P 140 ĀöüéêĆüßĊĚüĆé Center of excellence ðøąđõìêĆüßĊĚüĆé Infertility øĀĆÿêĆüßĊĚüĆé DE1305 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) ĂĆêøćÖćøêĆĚÜÙøøõŤêŠĂøĂïÖćøĔÿêŠ üĂĆ ŠĂî×ĂÜñĎšøĆïïøĉÖćøìĈđéĘÖĀúĂéĒÖšüĒúą÷ć÷ê š ĆüĂŠĂî øĂïĒߊĒ×ĘÜ (ÖúčŠöĂć÷č 34 - 39 ðŘ) ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Infertility: Clinical pregnancy rate per embryo transfer following IVF/ICSI and frozen embryo transfer (age 34 - 39 years) îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ÖćøìĈđéĘÖĀúĂéĒÖšü Āöć÷ëċÜ ÖćøĔßšđìÙēîēú÷Ċߊü÷ÖćøđÝøĉâóĆîíčŤéšü÷ÖćøðäĉÿîíĉîĂÖ øŠćÜÖć÷ ĂĆîĕéšĒÖŠÖćøñÿöîĂÖøŠćÜÖć÷ĔîÝćîđóćąđú÷ÜĊĚ (standard in vitro fertilisation) ĒúąÖćøÞĊéêĆüĂÿčÝĉđךćđàúúŤĕ׊ēé÷êøÜ (ICSI- intracytoplasmic sperm injection) ēé÷ ìĈÖćø÷šć÷êĆüĂŠĂîìñĊę ŠćîÖćøĒߊĒ×ĘÜ úąúć÷ Ēúą/ĀøČĂđóćąđúĊĚ÷ÜêŠĂĀúĆÜúąúć÷êĆüĂŠĂî đךćĔîēóøÜöéúĎÖ×ĂÜÿêøĊñĎšøĆïïøĉÖćø 2. Clinical pregnancy Āöć÷ëċÜ ÖćøêøüÝéšü÷đÙøČęĂÜÙüćöëĊęÿĎÜ ÷Čî÷ĆîÖćøêĆĚÜÙøøõŤ×ĂÜêĆü ĂŠĂîöĊßĊó (öĊÖćøđêšî×ĂÜĀĆüĔÝ) ĔîēóøÜöéúĎÖìĊęĂć÷čÙøøõŤ 6-8 ÿĆðéćĀŤĀøČĂ 3-5 ÿĆðéćĀŤ ĀúĆÜÖćøĔÿŠêĆüĂŠĂî üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíñúÖćøø ĉ ĆÖþćéšü÷đìÙēîēú÷Ċߊü÷ÖćøđÝøâóĉ ĆîíčŤ ÿĎêøĔîÖćøÙĈîüè (a/b) × 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîÿêøñĊĎšøĆïïøĉÖćøìĕéĊę šøïÖćø÷ Ć Čî÷ĆîÖćøêĆĚÜÙøøõŤ(ÖúöĂć÷ čŠ č 34 - 39 ð)Ř ìĊęöĊÖćø đêšî×ĂÜĀĆüĔÝìćøÖ ÝćÖÖćøêøüÝéšü÷đÙøČęĂÜÙüćöëĊęÿĎÜ ÝćÖÖćøĔÿŠêüĂĆ ŠĂîøĂïĒߊĒ×ĘÜĔîߊüÜ øą÷ąđüúćĀîċęÜðŘ êĆüĀćø b = ÝĈîüîÙøĆĚÜ×ĂÜÖćøĔÿŠêĆüĂŠĂî×ĂÜñĎšøĆïïøĉÖćøìĈđéĘÖĀúĂéĒÖšüĒúą÷šć÷êĆüĂŠĂî øĂïĒߊĒ×ĘÜìĆĚÜĀöé (ÖúöĂć÷ čŠ č 34 - 39 ð)ŘĔîߊüÜđüúćđéĊ÷üÖĆî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ êĆüĀćø ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖ 1 ðŘ (êĆüßĊĚüĆéøć÷ðŘ) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * ÿöćÙöîĆÖüĉì÷ćýćÿêøđóćąđú Ť ĊĚ÷ÜêĆüĂŠĂîĒĀŠÜðøąđìýĕì÷ ÿî.óì. üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÙèąĂîčÖøøöÖćøøąïïÙčèõćóĒúąóĆçîćêĆüßĊĚüĆé, đÙøČĂ׊ć÷ēøÜó÷ćïćúÖúöÿëćï čŠ Ćî Ēóì÷ýćÿêøŤĒĀŠÜðøąđìýĕì÷ (UHosNet) üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2560 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé Āöć÷đĀêč G DE1305

BY NC SA Thailand Hospital Indicator Program: THIP BENCHMARK KPI DICTIONARY 2024 T H I P 141 ĀöüéêĆüßĊĚüĆé Center of excellence ðøąđõìêĆüßĊĚüĆé Infertility øĀĆÿêĆüßĊĚüĆé DE1306 ßČęĂêĆüßĊĚüĆé (õćþćĕì÷) ĂĆêøćÖćøêĆĚÜÙøøõŤêŠĂøĂïÖćøĔÿêŠ üĂĆ ŠĂî×ĂÜñĎšøĆïïøĉÖćøìĈđéĘÖĀúĂéĒÖšüĒúą÷ć÷ê š ĆüĂŠĂî øĂïĒߊĒ×ĘÜ (ÖúčŠöĂć÷ 40 č ðŘ×ċĚîĕð) ßČęĂêĆüßĊĚüĆé (õćþćĂĆÜÖùþ) Infertility: Clinical pregnancy rate per embryo transfer following IVF/ICSI and frozen embryo transfer (age > 40 years) îĉ÷ćö ÙĈĂíĉïć÷ ÙüćöĀöć÷×ĂÜ êĆüßĊĚüĆé 1. ÖćøìĈđéĘÖĀúĂéĒÖšü Āöć÷ëċÜ ÖćøĔßšđìÙēîēú÷Ċߊü÷ÖćøđÝøĉâóĆîíčŤéšü÷ÖćøðäĉÿîíĉîĂÖ øŠćÜÖć÷ ĂĆîĕéšĒÖŠÖćøñÿöîĂÖøŠćÜÖć÷ĔîÝćîđóćąđú÷ÜĊĚ (standard in vitro fertilisation) ĒúąÖćøÞĊéêĆüĂÿčÝĉđךćđàúúŤĕ׊ēé÷êøÜ (ICSI- intracytoplasmic sperm injection) ēé÷ ìĈÖćø÷šć÷êĆüĂŠĂîìñĊę ŠćîÖćøĒߊĒ×ĘÜ úąúć÷ Ēúą/ĀøČĂđóćąđúĊĚ÷ÜêŠĂĀúĆÜúąúć÷êĆüĂŠĂî đךćĔîēóøÜöéúĎÖ×ĂÜÿêøĊñĎšøĆïïøĉÖćø 2. Clinical pregnancy Āöć÷ëċÜ ÖćøêøüÝéšü÷đÙøČęĂÜÙüćöëĊęÿĎÜ ÷Čî÷ĆîÖćøêĆĚÜÙøøõŤ×ĂÜêĆü ĂŠĂîöĊßĊó (öĊÖćøđêšî×ĂÜĀĆüĔÝ) ĔîēóøÜöéúĎÖìĊęĂć÷čÙøøõŤ 6-8 ÿĆðéćĀŤĀøČĂ 3-5 ÿĆðéćĀŤ ĀúĆÜÖćøĔÿŠêĆüĂŠĂî üĆêëčðøąÿÜÙŤ×ĂÜêĆüßĊĚüĆé ðøąđöĉîðøąÿĉìíĉñúÖćøøĆÖþćéšü÷đìÙēîēú÷Ċߊü÷ÖćøđÝøâóĉ ĆîíčŤ ÿĎêøĔîÖćøÙĈîüè (a/b) × 100 ךĂöĎúìĊęêšĂÜÖćø êĆüêĆĚÜ a = ÝĈîüîÿêøñĊĎšøĆïïøĉÖćøìĕéĊę šøïÖćø÷ Ć Čî÷ĆîÖćøêĆĚÜÙøøõŤ(ÖúöĂć÷ čŠ č40 ðŘ×ċĚîĕð) ìĊęöĊÖćø đêšî×ĂÜĀĆüĔÝìćøÖ ÝćÖÖćøêøüÝéšü÷đÙøČęĂÜÙüćöëĊęÿĎÜ ÝćÖÖćøĔÿŠêüĂĆ ŠĂîøĂïĒߊĒ×ĘÜĔîߊüÜ øą÷ąđüúćĀîċęÜðŘ êĆüĀćø b = ÝĈîüîÙøĆĚÜ×ĂÜÖćøĔÿŠêĆüĂŠĂî×ĂÜñĎšøĆïïøĉÖćøìĈđéĘÖĀúĂéĒÖšüĒúą÷šć÷êĆüĂŠĂî øĂïĒߊĒ×ĘÜìĆĚÜĀöé (ÖúöĂć÷ čŠ č40 ðŘ×ċĚîĕð) ĔîߊüÜđüúćđé÷üÖ Ċ Ćî øĀĆÿēøÙ/ ĀĆêëÖćø ìĊęđÖĊę÷üךĂÜ êĆüêĆĚÜ êĆüĀćø ÙüćöëĊęĔîÖćøÝĆéìĈךĂöúĎ ìčÖ 1 ðŘ (êĆüßĊĚüĆéøć÷ðŘ) ĀîŠü÷üĆé øšĂ÷úą Benchmark (ĒĀúŠÜĂšćÜĂĉÜ/ ðŘ) * ÿöćÙöîĆÖüĉì÷ćýćÿêøđóćąđú Ť ĊĚ÷ÜêĆüĂŠĂîĒĀŠÜðøąđìýĕì÷ ÿî.óì. üĉíĊÖćøĒðúñú ÙŠć÷ĉęÜöćÖ = öĊÙčèõćóéĊ ìĊęöć/ Reference ÙèąĂîčÖøøöÖćøøąïïÙčèõćóĒúąóĆçîćêĆüßĊĚüĆé, đÙøČĂ׊ć÷ēøÜó÷ćïćúÖúöÿëćï čŠ Ćî Ēóì÷ýćÿêøŤĒĀŠÜðøąđìýĕì÷ (UHosNet) üĆî đéČĂî ðŘìĊęđøĉęöĔßš 1 êčúćÙö 2560 üĆî đéČĂî ðŘìĊęðøĆïðøčÜÙøĆĚÜúŠćÿčé Āöć÷đĀêč G DE1306